FedInvent™ Patents

Patent Details for Tuesday, January 28, 2014 

This page was updated on Monday, March 27, 2023 at 03:56 AM GMT

Department of Health and Human Services (HHS) 

US 08635911 Son et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Sungmin Son (Cambridge, Massachusetts);  Sangwon Byun (Cambridge, Massachusetts);  Andrea Kristine Bryan (Allston, Massachusetts);  Thomas Burg (Goettingen, Germany);  Amneet Gulati (Cambridge, Massachusetts);  Jungchul Lee (Seoul, South Korea);  Scott Manalis (Cambridge, Massachusetts);  Yao-Chung Weng (Cambridge, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Sungmin Son (Cambridge, Massachusetts);  Sangwon Byun (Cambridge, Massachusetts);  Andrea Kristine Bryan (Allston, Massachusetts);  Thomas Burg (Goettingen, Germany);  Amneet Gulati (Cambridge, Massachusetts);  Jungchul Lee (Seoul, South Korea);  Scott Manalis (Cambridge, Massachusetts);  Yao-Chung Weng (Cambridge, Massachusetts)
ABSTRACT Method for determining buoyant mass and deformability of a cell. The method includes introducing the cell into a suspended microchannel resonator that includes a constriction near a distal location in the resonator. A first frequency shift in the resonator is monitored as a cell moves to the distal location in the resonator, the first frequency shift being related to the buoyant mass of the cell. Transit time of the cell through the constriction is measured by monitoring a second frequency shift as a result of a change in cell location as it passes through the constriction, whereby deformability is determined from the measured buoyant mass and transit time.
FILED Thursday, April 28, 2011
APPL NO 13/096248
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Measuring and testing
073/579
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636032 Burns et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Mark A. Burns (Ann Arbor, Michigan);  Sean M. Langelier (Ann Arbor, Michigan);  Dustin S. Chang (Mt. Laurel, New Jersey)
ASSIGNEE(S) National Institute of Health (NIH) (Washington, District of Columbia);  U.S. Dept. of Health and Human Services (DHHS) (Washington, District of Columbia);  U.S. Government of the United States as Represented by the NIH Division of Extramural Inventions and Technology Resources (DEITR) (Washington, District of Columbia)
INVENTOR(S) Mark A. Burns (Ann Arbor, Michigan);  Sean M. Langelier (Ann Arbor, Michigan);  Dustin S. Chang (Mt. Laurel, New Jersey)
ABSTRACT An acoustical fluid control mechanism and a method of controlling fluid flow of a working fluid with the acoustical fluid control mechanism are provided. The mechanism comprises a resonance chamber that defines a cavity. The resonance chamber has a port. The cavity is sealed from the ambient but for the port for enabling oscillatory flow of a working fluid into and out of the cavity upon exposure of the resonance chamber to an acoustic signal containing a tone at a frequency that is substantially similar to a particular resonance frequency of the resonance chamber. The mechanism further includes a rectifier for introducing directional bias to the oscillatory flow of the working fluid through the port. The rectifier has an inlet connected to the port and an outlet for transmitting the directional flow of the working fluid away from the cavity. The outlet is in fluid communication with the port of the resonance chamber at least during transmission of the directional flow of the working fluid therethrough.
FILED Friday, November 13, 2009
APPL NO 13/129276
ART UNIT 3753 — Fluid Handling and Dispensing
CURRENT CPC
Fluid handling
137/828
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636713 Prausnitz et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Mark R. Prausnitz (Atlanta, Georgia);  Henry F. Edelhauser (Atlanta, Georgia);  Samirkumar Rajnikant Patel (Atlanta, Georgia)
ASSIGNEE(S) Emory University (Atlanta, Georgia);  Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Mark R. Prausnitz (Atlanta, Georgia);  Henry F. Edelhauser (Atlanta, Georgia);  Samirkumar Rajnikant Patel (Atlanta, Georgia)
ABSTRACT Methods and devices are provided for targeted administration of a drug to a patient's eye. In one embodiment, the method includes inserting a hollow microneedle into the sclera of the eye at an insertion site and infusing a fluid drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused fluid drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. The fluid drug formulation may flow circumferentially toward the retinochoroidal tissue, macula, and optic nerve in the posterior segment of the eye.
FILED Monday, April 23, 2012
APPL NO 13/453407
ART UNIT 3763 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Surgery
64/521
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636978 Wood et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Bradford J. Wood (Potomac, Maryland);  Matthew Dreher (Rockville, Maryland);  Ayele H. Negussie (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Bradford J. Wood (Potomac, Maryland);  Matthew Dreher (Rockville, Maryland);  Ayele H. Negussie (Washington, District of Columbia)
ABSTRACT Cyclized peptide compounds containing the NGR motif of formula (I) or a pharmaceutically-acceptable salt thereof are disclosed. Compositions comprising the cyclized peptide compounds and methods of their use are also disclosed.
FILED Monday, June 15, 2009
APPL NO 13/000543
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/1.690
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636986 Van Dyke
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) Thomas E. Van Dyke (West Roxbury, Massachusetts)
ASSIGNEE(S) The Forsyth Institute (Cambridge, Massachusetts)
INVENTOR(S) Thomas E. Van Dyke (West Roxbury, Massachusetts)
ABSTRACT The present invention provides new methods for inducing or promoting bone growth and/or for reducing or preventing bone deterioration in a mammal subject. The inventive methods generally comprise administering to the subject an effective amount of a resolvin. In particular, the inventive methods may be useful for treating or preventing conditions associated with bone degradation, deterioration or degeneration such as periodontal disease, osteoarthritis, and metastatic bone disease and osteolytic bone disease. Pharmaceutical compositions and kits comprising at least one resolvin are also provided that can be used to performed the inventive methods.
FILED Friday, November 17, 2006
APPL NO 12/094016
ART UNIT 1612 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/49
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636997 Martin et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Roland Martin (Bethesda, Maryland);  Henry McFarland (Gaithersburg, Maryland);  Bibiana Bielekova (Kensington, Maryland);  Thomas Waldmann (Silver Spring, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Roland Martin (Bethesda, Maryland);  Henry McFarland (Gaithersburg, Maryland);  Bibiana Bielekova (Kensington, Maryland);  Thomas Waldmann (Silver Spring, Maryland)
ABSTRACT Disclosed is a method of administering an interleukin-2 receptor (IL-2R) antagonist to a subject to treat an autoimmune disease. In particular embodiments, the IL-2R antagonist is an anti-IL-2R monoclonal antibody specific for one or more chains of the IL-2R, such as the alpha-chain, for example daclizumab. In other particular embodiments the autoimmune disease is multiple sclerosis. In certain embodiments administration of interferon-beta is combined with administration of an antagonist of the IL-2R to provide significant clinical improvement in a subject with an autoimmune disease.
FILED Wednesday, September 12, 2012
APPL NO 13/612763
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/85.600
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636999 Pogliano et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Joe Pogliano (San Diego, California);  Alan Derman (San Diego, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Joe Pogliano (San Diego, California);  Alan Derman (San Diego, California)
ABSTRACT The invention provides compositions and methods for stable plasmid maintenance and protein expression in bacteria. Further provided are compositions and methods for promoting competence in bacteria that are otherwise not transformable.
FILED Wednesday, June 16, 2010
APPL NO 13/378516
ART UNIT 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/93.200
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637009 Landry et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Donald W. Landry (New York, New York);  James H. Woods (Ann Arbor, Michigan);  Roger K. Sunahara (Ann Arbor, Michigan);  Diwahar L. Narasimhan (Ann Arbor, Michigan);  Joanne MacDonald (New York, New York);  Milan N. Stojanovich (Fort Lee, New Jersey);  John J. Tesmer (Ann Arbor, Michigan);  Remy L. Brim (Farmington Hills, Michigan)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York);  The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Donald W. Landry (New York, New York);  James H. Woods (Ann Arbor, Michigan);  Roger K. Sunahara (Ann Arbor, Michigan);  Diwahar L. Narasimhan (Ann Arbor, Michigan);  Joanne MacDonald (New York, New York);  Milan N. Stojanovich (Fort Lee, New Jersey);  John J. Tesmer (Ann Arbor, Michigan);  Remy L. Brim (Farmington Hills, Michigan)
ABSTRACT Provided are compositions comprising a cocaine esterase (CocE) and a compound that thermostabilizes the CocE. Also provided are methods of thermostabilizing a cocaine esterase. Additionally provided are methods of treating a mammal undergoing a cocaine-induced condition. Methods of determining whether a compound is a thermostabilizing agent for a protein are also provided. Uses of the above-described compositions for the treatment of a cocaine-induced condition is additionally provided. Additionally provided is an isolated nucleic acid encoding a CocE polypeptide having the substitutions L169K and G173Q, and the CocE polypeptide encoded by that nucleic acid, and pharmaceutical compositions thereof. Further provided is the use of that composition for the manufacture of a medicament for the treatment of a cocaine-induced condition and for the treatment of a cocaine-induced condition.
FILED Thursday, July 10, 2008
APPL NO 12/667895
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/94.600
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637013 Liu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Yang Liu (Ann Arbor, Michigan);  Pan Zheng (Ann Arbor, Michigan);  Guo-Yun Chen (Ann Arbor, Michigan);  Xincheng Zheng (Ann Arbor, Michigan);  Xi Cheng (Woodland, California);  Steve Kunkel (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Yang Liu (Ann Arbor, Michigan);  Pan Zheng (Ann Arbor, Michigan);  Guo-Yun Chen (Ann Arbor, Michigan);  Xincheng Zheng (Ann Arbor, Michigan);  Xi Cheng (Woodland, California);  Steve Kunkel (Ann Arbor, Michigan)
ABSTRACT The present technology provides methods and compositions for the treatment of tissue-damage related immune dysregulation by administering a composition comprising one or more of CD24; CD24 fragments, variants and derivatives, CD24Fc fusion proteins; HMBG1-binding proteins, binding proteins to HMBG1 Box B; antagonists of HMGB1, polyclonal, monoclonal, recombinant, chimeric, humanized scFv antibodies and antibody fragments to HMGB1 or fragments of HMGB1 and antibodies that bind and suppress the activity of HMGB1 Box B; Siglec 10 agonists such as anti-Siglec 10 antibodies; and combinations thereof to a patient.
FILED Wednesday, March 21, 2012
APPL NO 13/426392
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/130.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637020 Choi et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Yongwon Choi (New York, New York);  Brian Wong (New York, New York)
ASSIGNEE(S) The Rockefeller University (New York, New York)
INVENTOR(S) Yongwon Choi (New York, New York);  Brian Wong (New York, New York)
ABSTRACT A method of modulating immune response in an animal is disclosed. Such a method interacting the immature dendritic cells from the animal with an antigen ex vivo so that the immature dendritic cells present the antigen on their surfaces, inducing maturation of the immature dendritic cells ex vivo, and contacting the mature dendritic cells ex vivo with a modulator comprising TRANCE, conservative variants thereof, fragments thereof, analogs or derivatives thereof, or a fusion protein comprising the amino acid sequence of TRANCE, conservative variants thereof, or fragments thereof. After contacting the modulator ex vivo, the mature dendritic cells are introduced into the animal. As a result, immune response in the animal towards the antigen is modulated relative to the immune response against the antigen in an animal in which dendritic cells did not interact with the antigen ex vivo, and did not contact a modulator ex vivo. Preferably, the method of the present invention results in increasing immune response towards the antigen in the animal.
FILED Wednesday, August 15, 2012
APPL NO 13/586514
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/133.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637028 Alexis et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Frank Alexis (Greenville, South Carolina);  Matteo Iannacone (Milan, Italy);  Jinjun Shi (Boston, Massachusetts);  Pamela Basto (Boston, Massachusetts);  Elliott Ashley Moseman (Jamaica Plain, Massachusetts);  Ulrich von Andrian (Chestnut Hill, Massachusetts);  Robert S. Langer (Newton, Massachusetts);  Omid C. Farokhzad (Waban, Massachusetts);  Elena Tonti (Riccione, Italy)
ASSIGNEE(S) President and Fellows of Harvard College (Cambridge, Massachusetts);  Massachusetts Institute of Technology (Cambridge, Massachusetts);  The Brigham and Women's Hospital (Boston, Massachusetts)
INVENTOR(S) Frank Alexis (Greenville, South Carolina);  Matteo Iannacone (Milan, Italy);  Jinjun Shi (Boston, Massachusetts);  Pamela Basto (Boston, Massachusetts);  Elliott Ashley Moseman (Jamaica Plain, Massachusetts);  Ulrich von Andrian (Chestnut Hill, Massachusetts);  Robert S. Langer (Newton, Massachusetts);  Omid C. Farokhzad (Waban, Massachusetts);  Elena Tonti (Riccione, Italy)
ABSTRACT The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable of stimulating an immune response in T cells and/or in B cells. The invention provides nanocarriers that comprise an immunofeature surface and an immunostimulatory moiety. In some embodiments, the immunostimulatory moiety is an adjuvant. The invention provides pharmaceutical compositions comprising inventive nanocarriers. The present invention provides methods of designing, manufacturing, and using inventive nanocarriers and pharmaceutical compositions thereof.
FILED Friday, October 09, 2009
APPL NO 13/123888
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/143.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637036 Mascola et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) John R. Mascola (Rockville, Maryland);  Richard T. Wyatt (San Diego, California);  Xueling Wu (Potomac, Maryland);  Yuxing Li (Boyds, Maryland);  Carl-Magnus Hogerkorp (Vellinge, Sweden);  Mario Roederer (Washington, District of Columbia);  Zhi-yong Yang (Potomac, Maryland);  Gary J. Nabel (Washington, District of Columbia);  Peter D. Kwong (Washington, District of Columbia);  Tongqing Zhou (Boyds, Maryland);  Mark Connors (Bethesda, Maryland);  William R. Schief (Encinitas, California)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia);  University of Washington (Seattle, Washington)
INVENTOR(S) John R. Mascola (Rockville, Maryland);  Richard T. Wyatt (San Diego, California);  Xueling Wu (Potomac, Maryland);  Yuxing Li (Boyds, Maryland);  Carl-Magnus Hogerkorp (Vellinge, Sweden);  Mario Roederer (Washington, District of Columbia);  Zhi-yong Yang (Potomac, Maryland);  Gary J. Nabel (Washington, District of Columbia);  Peter D. Kwong (Washington, District of Columbia);  Tongqing Zhou (Boyds, Maryland);  Mark Connors (Bethesda, Maryland);  William R. Schief (Encinitas, California)
ABSTRACT Monoclonal neutralizing antibodies are disclosed that specifically bind to the CD4 binding site of HIV-1 gp120. Monoclonal neutralizing antibodies also are disclosed that specifically bind to HIV-1 gp41. The identification of these antibodies, and the use of these antibodies are also disclosed. Methods are also provided for enhancing the binding and neutralizing activity of any antibody using epitope scaffold probes.
FILED Friday, March 23, 2012
APPL NO 13/429286
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/160.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637040 Whittum-Hudson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Judith Whittum-Hudson (Novi, Michigan);  Alan P. Hudson (Novi, Michigan)
ASSIGNEE(S) National Institute of Health (NIH), U.S. Dept. of Health and Human Services (DHHS) (Washington, District of Columbia)
INVENTOR(S) Judith Whittum-Hudson (Novi, Michigan);  Alan P. Hudson (Novi, Michigan)
ABSTRACT Peptides generated from a random library that are bound by a monoclonal antibody to Chlamydial glycolipid exoantigen (GLXA) and thus mimic this antigen are disclosed. Peptides that correspond to antigen-binding regions of an anti-idiotypic antibody (mAb2) specific for anti-GLXA antibody (Ab1) which act as molecular mimics of GLXA are also disclosed used as immunogens to induce broadly reactive genus-specific anti-chlamydial antibodies. These peptides and immunogenic DNA encoding the mAb2-like peptides, microparticle or nanoparticle formulations and other formulations of these peptides are disclosed as are methods for immunizing subjects to obtain genus-specific anti-chlamydial antibodies and to treat or prevent Chlamydia-associated or induced rheumatoid arthritis.
FILED Monday, September 21, 2009
APPL NO 13/120071
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/185.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637044 Barnett et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Susan Barnett (Emeryville, California);  Rino Rappuoli (Siena, Italy);  Victoria A Sharma (Emeryville, California);  Indresh K Srivastava (Emeryville, California);  Jan Zur Megede (Emeryville, California)
ASSIGNEE(S) Novartis AG (Basel, Switzerland)
INVENTOR(S) Susan Barnett (Emeryville, California);  Rino Rappuoli (Siena, Italy);  Victoria A Sharma (Emeryville, California);  Indresh K Srivastava (Emeryville, California);  Jan Zur Megede (Emeryville, California)
ABSTRACT Hybrid molecules comprising CD4 minimal modules or mimetics that bind to HIV Env polypeptides in combination with one or more HIV Tat polypeptides are described. Also described are complexes of these hybrid molecules with Env as well as methods of diagnosis, treatment and prevention using the polynucleotides and polypeptides.
FILED Thursday, March 22, 2012
APPL NO 13/427234
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/192.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637050 Beall et al.
FUNDED BY
Department of Health and Human Services (HHS)
Centers for Disease Control and Prevention (CDC)
APPLICANT(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services, Centers for Disease Control and Prevention (Washington, District of Columbia)
INVENTOR(S) Bernard W. Beall (Doraville, Georgia);  George M. Carlone (Stone Mountain, Georgia);  Jacquelyn S. Sampson (College Park, Georgia);  Edwin W. Ades (Atlanta, Georgia)
ABSTRACT This invention, in one aspect, relates to synthetic immunoreactive peptides. These peptides are approximately 20-25 amino acids in length which are portions of the N termini of the M proteins of the most prevalent United States (U.S.) Group A Streptococcus (GAS) serotypes. At least some of the synthetic peptides can be recognized by M type-specific antibodies and are capable of eliciting functional opsonic antibodies and/or anti-attachment antibodies without eliciting tissue cross-reactive antibodies. In another aspect, it relates to compositions or vaccines comprising these synthetic serotype-specific peptides, including polypeptides and proteins. The invention may also be isolated antibodies which are raised in response to the peptides, compositions or vaccines. The invention further relates to kits for using the peptides, compositions, or antibodies. In still further aspects, the invention also relates to methods for using the peptides, compositions, vaccines, or antibodies and methods for tailoring vaccines.
FILED Monday, March 18, 2013
APPL NO 13/846166
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/244.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637065 Athanasiou et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Kyriacos A. Athanasiou (Houston, Texas);  Ying Deng (Sioux Falls, South Dakota);  Jerry Hu (Houston, Texas)
ASSIGNEE(S) William Marsh Rice University (Houston, Texas)
INVENTOR(S) Kyriacos A. Athanasiou (Houston, Texas);  Ying Deng (Sioux Falls, South Dakota);  Jerry Hu (Houston, Texas)
ABSTRACT Methods for inducing differentiation of dermis-derived cells to serve as a source of chondrocytes and associated methods of use in forming tissue engineered constructs. One example of a method is a method for inducing differentiation of cells into chondrocytes comprising providing aggrecan sensitive isolated dermis cells and seeding the cells onto an aggrecan coated surface.
FILED Monday, October 06, 2008
APPL NO 12/246320
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/423
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637074 Castor
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Trevor Percival Castor (Arlington, Massachusetts)
ASSIGNEE(S) Aphios Corporation (Woburn, Massachusetts)
INVENTOR(S) Trevor Percival Castor (Arlington, Massachusetts)
ABSTRACT This invention is for an improved process to co-encapsulate hydrophobic drugs and hydrophilic drugs in phospholipid liposomes. Non-toxic supercritical or near-critical fluids with/without polar cosolvents are utilized to solubilize phospholipid materials and hydrophobic drugs, and form uniform liposomes to encapsulate hydrophobic drugs and hydrophilic drugs.
FILED Tuesday, March 31, 2009
APPL NO 12/384007
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/450
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637090 Ohtake et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Satoshi Ohtake (Milpitas, California);  Vu Truong-Le (Campbell, California);  David Lechuga-Ballesteros (San Jose, California);  Luisa Yee (Los Altos, California);  Binh V Pham (Mountain View, California);  Russell Martin (Los Gatos, California);  Atul Saxena (Milpitas, California)
ASSIGNEE(S) Aridis Pharmaceuticals (San Jose, California)
INVENTOR(S) Satoshi Ohtake (Milpitas, California);  Vu Truong-Le (Campbell, California);  David Lechuga-Ballesteros (San Jose, California);  Luisa Yee (Los Altos, California);  Binh V Pham (Mountain View, California);  Russell Martin (Los Gatos, California);  Atul Saxena (Milpitas, California)
ABSTRACT A method and composition for treatment of bacterial infections caused by gram negative or gram positive bacteria such as Staphylococcus aureus, Rhodococcus equi, Mycobacterium tuberculosis, Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a formulation containing gallium (III), in a pharmaceutically acceptable salt or complex thereof.
FILED Tuesday, May 04, 2010
APPL NO 13/318774
ART UNIT 1617 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/650
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637232 Lama
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Vibha Lama (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Vibha Lama (Ann Arbor, Michigan)
ABSTRACT The present invention pertains to the monitoring and treatment of lung transplant recipients. In particular, the invention pertains to the use of biomarkers to predict or detect post-lung transplantation complications (e.g., organ rejection, acute organ rejection, organ injury, bronchiolitis obliterans, bronchiolitis obliterans syndrome, organizing pneumonia), fibroproliferative repair responses, interstitial lung diseases (e.g., idiopathic pulmonary fibrosis and other fibrotic lung diseases), and other immune-mediated lung diseases (e.g., graft versus host disease, scleroderma).
FILED Friday, January 21, 2011
APPL NO 13/011541
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/4
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637234 Shaw et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) George M. Shaw (Birmingham, Alabama);  James E. Robinson (New Orleans, Louisiana);  Frederic Bibollet-Ruche (Birmingham, Alabama);  Julie M. Decker (Alabaster, Alabama);  Beatrice H. Hahn (Birmingham, Alabama);  Peter D. Kwong (Bethesda, Maryland)
ASSIGNEE(S) UAB Research Foundation (Birmingham, Alabama);  The Administrators of Tulane Educational Fund (New Orleans, Louisiana);  The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) George M. Shaw (Birmingham, Alabama);  James E. Robinson (New Orleans, Louisiana);  Frederic Bibollet-Ruche (Birmingham, Alabama);  Julie M. Decker (Alabaster, Alabama);  Beatrice H. Hahn (Birmingham, Alabama);  Peter D. Kwong (Bethesda, Maryland)
ABSTRACT Methods and compositions are provided for the use of an envelope polypeptide or a functional variant thereof from a lentivirus that is not HIV-1 as a molecular scaffold for HIV-1 epitopes. The HIV-1 epitopes can be recognized by HIV-1 binding antibodies, HIV-1 neutralizing antibodies and/or CD4-induced antibodies. Thus, methods are provided for detecting HIV-1 binding antibodies in a subject infected with HTV-1. Further provided are methods to determine an epitope for an HIV-1 binding antibody; methods to assay for an HIV-1 binding antibody; methods to identify a soluble CD4 mimic; methods to neutralize an non-HIV-1 virus; diagnostic assays to monitor HIV disease in a subject or to monitor the subject's response to immunization by a HIV vaccine; and methods to alter the neutralization potential of an HIV-1 derived CD4-induced antibody. Chimeric polypeptides, chimeric polynucleotides, kits, cells and viruses are also provided.
FILED Friday, April 08, 2005
APPL NO 11/578761
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/5
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637237 Henrich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Department of Agriculture (USDA)
APPLICANT(S) Vincent C. Henrich (Greensboro, North Carolina);  Cary Alan Weinberger (Carrboro, North Carolina)
ASSIGNEE(S) The University of North Carolina at Greensboro (Greensboro, North Carolina)
INVENTOR(S) Vincent C. Henrich (Greensboro, North Carolina);  Cary Alan Weinberger (Carrboro, North Carolina)
ABSTRACT Ecdysteroid action in Drosophila melanogaster and other insects is mediated by the dimerization of two nuclear receptors, the ecdysone receptor (EcR) and Ultraspiracle (USP), which regulate the transcription of target genes. Disclosed are nucleic acid constructs to identify insecticides having the ability to modify insect development and growth in a developmental stage-specific and/or species-specific manner.
FILED Thursday, October 05, 2006
APPL NO 11/543682
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637239 Furuta et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Glenn T. Furuta (Aurora, Colorado);  Steven J. Ackerman (Naperville, Illinois)
ASSIGNEE(S) The Board of Trustees of the University of Illinois (Urbana, Illinois);  The Regents of the University of Colorado, A Body Corporate (Denver, Colorado)
INVENTOR(S) Glenn T. Furuta (Aurora, Colorado);  Steven J. Ackerman (Naperville, Illinois)
ABSTRACT The methods and apparatus of the present invention allow the evaluation of inflammation of the esophagus. Measurements may be utilized, for example, to diagnose a disease of the esophagus, to monitor inflammation of the esophagus, or to access the treatment of a disease of the esophagus. In one embodiment, the invention comprises a method for measuring esophageal inflammation comprising deploying a device into the esophagus of a subject, removing the device after a predetermined period of time, analyzing the device for a diagnostic indicator of esophageal inflammation and evaluating the diagnostic indicator to diagnose esophageal inflammation.
FILED Wednesday, November 05, 2008
APPL NO 12/741549
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637240 Tian et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Qiang Tian (Seattle, Washington);  Greg D. Foltz (Seattle, Washington);  Leroy Hood (Seattle, Washington);  Xiaowei Yan (Bellevue, Washington)
ASSIGNEE(S) Institute for Systems Biology (Seattle, Washington)
INVENTOR(S) Qiang Tian (Seattle, Washington);  Greg D. Foltz (Seattle, Washington);  Leroy Hood (Seattle, Washington);  Xiaowei Yan (Bellevue, Washington)
ABSTRACT Signatures indicative of cancer grades are based on over- and under-expression of 214 genes that characterize expression patterns in CD133+ cells.
FILED Tuesday, September 28, 2010
APPL NO 12/892710
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637243 Benkovic et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Stephen J Benkovic (State College, Pennsylvania);  Frank Salinas (Wheaton, Illinois)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Stephen J Benkovic (State College, Pennsylvania);  Frank Salinas (Wheaton, Illinois)
ABSTRACT A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.
FILED Thursday, December 20, 2012
APPL NO 13/722497
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637246 Garraway et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Levi Garraway (Newton, Massachusetts);  Caroline Emery (Brookline, Massachusetts)
ASSIGNEE(S) Dana-Farber Cancer Institute, Inc. (Boston, Massachusetts)
INVENTOR(S) Levi Garraway (Newton, Massachusetts);  Caroline Emery (Brookline, Massachusetts)
ABSTRACT The present invention relates to methods, compositions and kits concerning resistance to treatment with an anti-cancer agent, specifically an inhibitor of BRAF. In particular embodiments, the invention concerns mutations in a BRAF sequence that confer resistance to a BRAF inhibitor. Identification of such mutations in a BRAF sequence allows the identification and design of second-generation BRAF inhibitors. Methods and kits for detecting the presence of a mutant BRAF sequence in a sample are also provided.
FILED Tuesday, February 22, 2011
APPL NO 13/580651
ART UNIT 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.110
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637255 Wilson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) James M. Wilson (Glen Mills, Pennsylvania);  Weidong Xiao (Fort Washington, Pennsylvania)
ASSIGNEE(S) The Trustees of the University of Pennsylvania (Philadelphia, Pennsylvania)
INVENTOR(S) James M. Wilson (Glen Mills, Pennsylvania);  Weidong Xiao (Fort Washington, Pennsylvania)
ABSTRACT The nucleic acid sequences of adeno-associated virus (AAV) serotype 1 are provided, as are vectors and host cells containing these sequences and functional fragments thereof. Also provided are methods of delivering genes via AAV-1 derived vectors.
FILED Wednesday, March 16, 2011
APPL NO 13/048936
ART UNIT 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.190
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637261 Sklar et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Larry A Sklar (Albuquerque, New Mexico);  Bruce Edwards (Albuquerque, New Mexico);  Frederick Kuckuck (Albuquerque, New Mexico)
ASSIGNEE(S) STC.UNM (, New Mexico)
INVENTOR(S) Larry A Sklar (Albuquerque, New Mexico);  Bruce Edwards (Albuquerque, New Mexico);  Frederick Kuckuck (Albuquerque, New Mexico)
ABSTRACT The present invention, provides a flow cytometry apparatus for the detection of particles from a plurality of samples comprising: means for moving a plurality of samples comprising particles from a plurality of respective source wells into a fluid flow stream; means for introducing a separation gas between each of the plurality of samples in the fluid flow stream; and means for selectively analyzing each of the plurality of samples for the particles. The present invention also provides a flow cytometry method employing such an apparatus.
FILED Tuesday, August 14, 2012
APPL NO 13/585165
ART UNIT 1641 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/7.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637267 Keiler et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Defense Threat Reduction Agency (DTRA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Kenneth C. Keiler (Boalsburg, Pennsylvania);  Stephen J. Benkovic (State College, Pennsylvania)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Kenneth C. Keiler (Boalsburg, Pennsylvania);  Stephen J. Benkovic (State College, Pennsylvania)
ABSTRACT Inhibitors of the tmRNA pathway have antibacterial activity with broad species specificity, including B. anthracis and other pathogens of military and civilian interest. Identified cyclic or linear peptides are further selected by in vivo selection methods, kill bacterial pathogens when added exogenously, and/or eliminate plasmids carrying antibiotic resistance or virulence genes. The molecular target of each cyclic peptide is in the tmRNA pathway and the tmRNA pathway is inhibited in vitro and in vivo by the addition of the peptides.
FILED Monday, April 28, 2008
APPL NO 12/111096
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/8
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637268 Chen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Junmei Chen (Seattle, Washington);  Dominic W. Chung (Bellevue, Washington);  Jose Aron Lopez (Seattle, Washington)
ASSIGNEE(S) Puget Sound Blood Center (Seattle, Washington)
INVENTOR(S) Junmei Chen (Seattle, Washington);  Dominic W. Chung (Bellevue, Washington);  Jose Aron Lopez (Seattle, Washington)
ABSTRACT Novel methods are described for measuring the rate of ADAMTS13-mediated cleavage of von Willebrand Factor (VWF) multimers. Through the use of the reagent, ristocetin, the method can advantageously be performed in the absence of an applied shear stress or added denaturing agent. Also described are methods for diagnosing ADAMTS13-associated disorders and methods for providing improved treatment of those disorders by evaluating the efficacy of the treatment using the methods as described.
FILED Friday, November 04, 2011
APPL NO 13/289474
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/13
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637287 Thorson et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Jon S. Thorson (Middleton, Wisconsin);  Richard W. Gantt (Roswell, Georgia)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Jon S. Thorson (Middleton, Wisconsin);  Richard W. Gantt (Roswell, Georgia)
ABSTRACT The present invention generally relates to materials and methods for exploiting glycosyltransferase reversibility for nucleotide diphosphate (NDP) sugar synthesis. The present invention provides engineered glycosyltransferase enzymes characterized by improved reaction reversibility and expanded sugar donor specificity as compared to corresponding non-mutated glycosyltransferase enzymes. Such reagents provide advantageous routes to NDP sugars for subsequent use in a variety of biomedical applications, including enzymatic and chemoenzymatic glycorandomization.
FILED Monday, June 13, 2011
APPL NO 13/159097
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/193
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637301 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Science Foundation (NSF)
APPLICANT(S) Jeff Tza-Huei Wang (Baltimore, Maryland);  Kelvin J. Liu (Baltimore, Maryland);  Christopher M. Puleo (Glenville, New York);  Tushar D. Rane (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Jeff Tza-Huei Wang (Baltimore, Maryland);  Kelvin J. Liu (Baltimore, Maryland);  Christopher M. Puleo (Glenville, New York);  Tushar D. Rane (Baltimore, Maryland)
ABSTRACT A microfluidic device for a confocal fluorescence detection system has an input channel defined by a body of the microfluidic device, a sample concentration section defined by the body of the microfluidic device and in fluid connection with the input channel, a mixing section defined by the body of the microfluidic device and in fluid connection with the concentration section, and a detection region that is at least partially transparent to illumination light of the confocal fluorescence detection system and at least partially transparent to fluorescent light when emitted from a sample under observation as the sample flows through the detection region.
FILED Tuesday, March 02, 2010
APPL NO 13/147742
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/283.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637306 Young et al.
FUNDED BY
Department of Energy (DOE)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Travis Young (San Diego, California);  Peter G. Schultz (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) Travis Young (San Diego, California);  Peter G. Schultz (La Jolla, California)
ABSTRACT Provided are methods of making carrier polypeptide that include incorporating a first unnatural amino acid into a carrier polypeptide variant, incorporating a second unnatural amino acid into a target polypeptide variant, and reacting the first and second unnatural amino acids to produce the conjugate. Conjugates produced using the provided methods are also provided. In addition, orthogonal translation systems in methylotrophic yeast and methods of using these systems to produce carrier and target polypeptide variants comprising unnatural amino acids are provided.
FILED Wednesday, December 09, 2009
APPL NO 12/653274
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/325
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637310 McBride et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) Alison McBride (Bethesda, Maryland);  Sandra Chapman (Washington, District of Columbia);  Jonathan Vogel (Bethesda, Maryland);  Atsushi Terunuma (Rockville, Maryland)
ASSIGNEE(S) The United States of America, as represented by the Secretary, Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) Alison McBride (Bethesda, Maryland);  Sandra Chapman (Washington, District of Columbia);  Jonathan Vogel (Bethesda, Maryland);  Atsushi Terunuma (Rockville, Maryland)
ABSTRACT Disclosed herein is the finding that treatment with a ROCK inhibitor increases proliferation and induces immortalization of primary keratinocytes. Accordingly, provided is a method of immortalizing primary keratinocytes by exposure to a ROCK inhibitor. Also provided are immortalized primary keratinocytes produced by the described method, as well as organotypic tissue equivalents and cell cultures comprising the immortalized primary keratinocytes. Furthermore, ROCK inhibitor-treated cells show a greatly increased ability to support viral DNA replication of both “low risk” and “high risk” HPV genomes, indicating that ROCK inhibitors will be useful for studying the life cycles of a wide range of HPVs.
FILED Friday, December 04, 2009
APPL NO 13/132391
ART UNIT 1653 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/377
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637313 Chamberlain et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Jeffrey S. Chamberlain (Seattle, Washington);  Dennis J. Hartigan-O'Connor (S Lake Tahoe, California)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Jeffrey S. Chamberlain (Seattle, Washington);  Dennis J. Hartigan-O'Connor (S Lake Tahoe, California)
ABSTRACT The present invention relates to methods and compositions for the production of viral vectors. In particular, the present invention provides methods and compositions for faster, higher titer and higher purity production of viral vectors (e.g. adenoviral vectors). In some embodiments, the present invention provides gutted and helper viruses with identical or similar termini. In other embodiments, the present invention provides terminal protein linked adenoviral DNA. In certain embodiments, the present invention provides template extended adenoviral DNA.
FILED Thursday, September 16, 2010
APPL NO 12/884027
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/457
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637317 Pamula et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Vamsee K. Pamula (Durham, North Carolina);  Arjun Sudarsan (Durham, North Carolina);  Ramakrishna Sista (Morrisville, North Carolina)
ASSIGNEE(S) Advanced Liquid Logic, Inc. (Morrisville, North Carolina)
INVENTOR(S) Vamsee K. Pamula (Durham, North Carolina);  Arjun Sudarsan (Durham, North Carolina);  Ramakrishna Sista (Morrisville, North Carolina)
ABSTRACT The invention provides a method of redistributing magnetically responsive beads in a droplet. The method may include providing a droplet including magnetically responsive beads. The droplet may be provided within a region of a magnetic field having sufficient strength to attract the magnetically responsive beads to an edge of the droplet or towards an edge of the droplet, or otherwise regionalize or aggregate beads within the droplet. The method may also include conducting on a droplet operations surface one or more droplet operations using the droplet without removing the magnetically responsive beads from the region of the magnetic field. The droplet operations may in some cases be electrode-mediated. The droplet operations may redistribute and/or circulate the magnetically responsive beads within the droplet. In some cases, the droplet may include a sample droplet may include a target analyte. The redistributing of the magnetically responsive beads may cause target analyte to bind to the magnetically responsive beads. In some cases, the droplet may include unbound substances in a wash buffer. The redistributing of the magnetically responsive beads causes unbound substances to be freed from interstices of an aggregated set or subset of the magnetically responsive beads.
FILED Thursday, January 06, 2011
APPL NO 12/985409
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemistry: Analytical and immunological testing
436/43
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637324 Pollack et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Michael G. Pollack (Durham, North Carolina);  Vamsee K. Pamula (Durham, North Carolina);  Ramakrishna Sista (Morrisville, North Carolina);  Arjun Sudarsan (Cary, North Carolina)
ASSIGNEE(S) Advanced Liquid Logic, Inc. (Morrisville, North Carolina)
INVENTOR(S) Michael G. Pollack (Durham, North Carolina);  Vamsee K. Pamula (Durham, North Carolina);  Ramakrishna Sista (Morrisville, North Carolina);  Arjun Sudarsan (Cary, North Carolina)
ABSTRACT The present invention relates to bead incubating and washing on a droplet actuator. Methods for incubating magnetically responsive beads that are labeled with primary antibody, a sample (i.e., analyte), and secondary reporter antibodies on a magnet, on and off a magnet, and completely off a magnet are provided. Also provided are methods for washing magnetically responsive beads using shape-assisted merging of droplets. Also provided are methods for shape-mediated splitting, transporting, and dispensing of a sample droplet that contains magnetically responsive beads. The apparatuses and methods of the invention provide for rapid time to result and optimum detection of an analyte in an immunoassay.
FILED Thursday, April 07, 2011
APPL NO 13/081927
ART UNIT 1779 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Chemistry: Analytical and immunological testing
436/180
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637325 Basile et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
Department of Agriculture (USDA)
APPLICANT(S) Franco Basile (Fort Collins, Colorado);  Shaofeng Zhang (Exton, Pennsylvania)
ASSIGNEE(S) University of Wyoming (Laramie, Wyoming)
INVENTOR(S) Franco Basile (Fort Collins, Colorado);  Shaofeng Zhang (Exton, Pennsylvania)
ABSTRACT A method and apparatus for conducting the rapid pyrolysis of peptides, proteins, polymers, and biological materials. The method can be carried out at atmospheric pressures and takes only about 5 to 30 seconds. The samples are cleaved at the C-terminus of aspartic acid. The apparatus employs a probe on which the sample is heated and digested components analyzed.
FILED Monday, February 16, 2009
APPL NO 12/371893
ART UNIT 2881 — Optics
CURRENT CPC
Chemistry: Analytical and immunological testing
436/501
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637448 Fay et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Philip J. Fay (Pittsford, New York);  Hironao Wakabayashi (Rochester, New York)
ASSIGNEE(S) University of Rochester (Rochester, New York)
INVENTOR(S) Philip J. Fay (Pittsford, New York);  Hironao Wakabayashi (Rochester, New York)
ABSTRACT The invention relates to a recombinant factor VIII that includes one or more mutations at an interface of A1 and C2 domains of recombinant factor VIII. The one or more mutations include substitution of one or more amino acid residues with either a cysteine or an amino acid residue having a higher hydrophobicity. This results in enhanced stability of factor VIII. Methods for making the recombinant factor VIII, pharmaceutical compositions containing the recombinant factor VIII, and use of the recombinant factor VIII for treating hemophilia A are also disclosed.
FILED Tuesday, September 13, 2011
APPL NO 13/231948
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/1.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637455 Darby et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Dental and Craniofacial Research (NIDCR)
APPLICANT(S) Martyn K. Darby (Chapel Hill, North Carolina);  Isaac G. Sanford (Durham, North Carolina);  R. Edward Benson (Durham, North Carolina);  Hanne Gron (Durham, North Carolina);  Paul T. Hamilton (Cary, North Carolina);  Shrikumar A. Nair (Cary, North Carolina);  Doug Buechter (Chester Springs, Pennsylvania);  Elliott Gruskin (Malvern, Pennsylvania)
ASSIGNEE(S) Affinergy, LLC (RTP, North Carolina);  DePuy Synthes Products, LLC (Raynham, Massachusetts)
INVENTOR(S) Martyn K. Darby (Chapel Hill, North Carolina);  Isaac G. Sanford (Durham, North Carolina);  R. Edward Benson (Durham, North Carolina);  Hanne Gron (Durham, North Carolina);  Paul T. Hamilton (Cary, North Carolina);  Shrikumar A. Nair (Cary, North Carolina);  Doug Buechter (Chester Springs, Pennsylvania);  Elliott Gruskin (Malvern, Pennsylvania)
ABSTRACT The presently disclosed subject matter relates to peptides having binding affinity for glycopeptide antibiotics and methods and compositions for delivering glycopeptide antibiotic to the surface of medical devices. The peptide compositions can comprise a peptide having binding affinity for a surface material of a medical device that is coupled to the peptide having binding affinity for glycopeptide antibiotic. Also provided are methods of applying the peptide compositions to a medical device by contacting the peptide compositions with a surface of the medical device. In addition, kits are provided comprising the peptide compositions.
FILED Friday, October 17, 2008
APPL NO 12/739353
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/3.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637456 Sasisekharan et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Ram Sasisekharan (Cambridge, Massachusetts);  Karthik Viswanathan (Waltham, Massachusetts);  Venkataramanan Soundararajan (Cambridge, Massachusetts);  S. Raguram (Hillsborough, New Jersey);  Viswanathan Sasisekharan (Cambridge, Massachusetts);  Vidya Subramanian (Somerville, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Ram Sasisekharan (Cambridge, Massachusetts);  Karthik Viswanathan (Waltham, Massachusetts);  Venkataramanan Soundararajan (Cambridge, Massachusetts);  S. Raguram (Hillsborough, New Jersey);  Viswanathan Sasisekharan (Cambridge, Massachusetts);  Vidya Subramanian (Somerville, Massachusetts)
ABSTRACT The present invention provides novel agents for broad spectrum influenza neutralization. The present invention provides agents for inhibiting influenza infection by bind to the influenza virus and/or hemagglutinin (HA) polypeptides and/or HA receptors, and reagents and methods relating thereto. The present invention provides a system for analyzing interactions between infolds and the interaction partners that bind to them.
FILED Thursday, January 27, 2011
APPL NO 13/015455
ART UNIT 1654 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/3.700
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637459 Srinivasan
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICANT(S) Shanthi Srinivasan (Atlanta, Georgia)
ASSIGNEE(S) Emory University (Atlanta, Georgia)
INVENTOR(S) Shanthi Srinivasan (Atlanta, Georgia)
ABSTRACT Provided herein are pharmaceutical and transplant compositions and methods related to the treatment and prevention of diabetes. More specifically, the compositions and methods are related to activation of glial derived neurotrophic factor (GDNF) receptors or overexpression of the GFR-α1/c-Ret receptor complex in insulin secreting cells so as to promote cell survival and proliferation.
FILED Wednesday, November 07, 2007
APPL NO 11/936413
ART UNIT 1633 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/6.700
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637462 Simari et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
APPLICANT(S) Robert D. Simari (Rochester, Minnesota);  Sinny Delacroix (Rochester, Minnesota)
ASSIGNEE(S) Mayo Foundation for Medical Education and Research (Rochester, Minnesota)
INVENTOR(S) Robert D. Simari (Rochester, Minnesota);  Sinny Delacroix (Rochester, Minnesota)
ABSTRACT This document relates to methods and materials for treating diseases or disorders associated with elevated platelet counts (e.g., essential thrombocythemia, secondary thrombocytosis, congenital amegakaryocytic thrombocytopenia, sepsis, or asplenism) as well as methods and materials for treating diseases or disorders associated with elevated platelet adhesion to collagen (e.g., acute coronary syndromes, angina pectoris, chronic atherosclerosis, diabetes, or hypertension).
FILED Friday, January 27, 2012
APPL NO 13/360039
ART UNIT 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/13.800
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637468 Peterson
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Blake R. Peterson (Lawrence, Kansas)
ASSIGNEE(S) The University of Kansas (Lawrence, Kansas)
INVENTOR(S) Blake R. Peterson (Lawrence, Kansas)
ABSTRACT Synthetic cholesterylamine-linkers can include derivatives of cholesterol, cholesteryl, or sitosteryl coupled through the linker to an agent for delivery into cells. The cholesterylamines are thought to mimic cholesterol in the capacity and mechanism for enhanced entry into cells. The configuration of the cholesterylamine-linker that is thought to provide for enhanced entry into cells includes a cholesterylamine that is coupled to a linker from the amine, and which linker includes a negative charge at a spatial distance from the amine of the cholesterylamine.
FILED Thursday, August 12, 2010
APPL NO 13/390327
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/20.900
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637472 Michael et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Scott F. Michael (Estero, Florida);  Sharon Isern (Estero, Florida);  Joshua Costin (Naples, Florida);  Vaikuntanath Samudrala (Seattle, Washington);  Ekachai Jenwitheesuk (Ratchaburi, Thailand)
ASSIGNEE(S) University of Washington Through Its Center for Commercialization (Seattle, Washington);  Florida Gulf Coast University (Ft. Myers, Florida)
INVENTOR(S) Scott F. Michael (Estero, Florida);  Sharon Isern (Estero, Florida);  Joshua Costin (Naples, Florida);  Vaikuntanath Samudrala (Seattle, Washington);  Ekachai Jenwitheesuk (Ratchaburi, Thailand)
ABSTRACT The invention relates peptide entry inhibitors and methods of determining such inhibitors that are bindable to regions of viruses having class II E proteins, such as the dengue virus E protein, as candidates for in vivo anti-viral compounds.
FILED Friday, July 11, 2008
APPL NO 12/668808
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/21.400
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637485 Secrist, III et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) John A. Secrist, III (Birmingham, Alabama);  Steven Ealick (Ithaca, New York);  Shridhar Bale (Ithaca, New York);  Anthony E. Pegg (Hershey, Pennsylvania);  Diane E. McCloskey (Hershey, Pennsylvania);  Wayne C. Guida (St. Pete Beach, Florida)
ASSIGNEE(S) Southern Research Institute (Birmingham, Alabama);  Cornell University (Ithica, New York);  H. Lee Moffitt Cancer and Research Institute (Tampa, Florida);  The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) John A. Secrist, III (Birmingham, Alabama);  Steven Ealick (Ithaca, New York);  Shridhar Bale (Ithaca, New York);  Anthony E. Pegg (Hershey, Pennsylvania);  Diane E. McCloskey (Hershey, Pennsylvania);  Wayne C. Guida (St. Pete Beach, Florida)
ABSTRACT The crystal structure of the complex of S-adenosylmethionine methyl ester with hΛdoMetDC F223A, a mutant where the stacking of the aromatic rings of F7, adenine and F223 would be eliminated. The structure of this mutant with the ester shows that the ligand still maintains a syn conformation aided by pi-pi interactions to F7, hydrogen bonds to the backbone of Glu67, and electrostatic interactions. Several series of AdoMet substrate analogues with a variety of substituents at the 8 position of adenine were synthesized and analyzed for their ability to inhibit hAdoMetDC. To understand these results, virtual modeling of the enzyme inhibitor complexes and the crystal structures of human AdoMetDC with 5′-deoxy-5′-[N-methyl-N-[2-(aminooxy)ethyl]amino-8-methyl]adenosine (MAOEMA) and 5′-deoxy-5′-[N-methyl-N-[4-(aminooxy)butyl]amino-8-ethyl]adenosine (MAOBEA) at the active site have been determined experimentally.
FILED Friday, August 01, 2008
APPL NO 12/671121
ART UNIT 1623 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/46
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637490 Peng et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Xiaohua Peng (Milwaukee, Wisconsin);  Yunyan Kuang (Shanghai, China PRC);  Sheng Cao (Milwaukee, Wisconsin);  Wenbing Chen (Milwaukee, Wisconsin);  Yibin Wang (Milwaukee, Wisconsin)
ASSIGNEE(S) UWM Research Foundation, Inc. (Milwaukee, Wisconsin)
INVENTOR(S) Xiaohua Peng (Milwaukee, Wisconsin);  Yunyan Kuang (Shanghai, China PRC);  Sheng Cao (Milwaukee, Wisconsin);  Wenbing Chen (Milwaukee, Wisconsin);  Yibin Wang (Milwaukee, Wisconsin)
ABSTRACT Described herein are compounds that may be selectively activated to produce active anti-cancer agents in tumor cells. Also disclosed are pharmaceutical compositions comprising the compounds, and methods of treating cancer using the compounds.
FILED Sunday, July 01, 2012
APPL NO 13/539471
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/64
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637493 Ross et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Alonzo H. Ross (Shrewsbury, Massachusetts);  Candace Gilbert (Worcester, Massachusetts);  Richard Moser (Worcester, Massachusetts)
ASSIGNEE(S) University of Massachusetts (Shrewsbury, Massachusetts)
INVENTOR(S) Alonzo H. Ross (Shrewsbury, Massachusetts);  Candace Gilbert (Worcester, Massachusetts);  Richard Moser (Worcester, Massachusetts)
ABSTRACT Described are methods for treating cancers, e.g., glioblastoma, including administering an inhibitor of Notch signalling, e.g., a gamma secretase inhibitor, in combination with a chemotherapeutic agent.
FILED Wednesday, November 10, 2010
APPL NO 12/943666
ART UNIT 1627 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/155
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637560 Trenkle et al.
FUNDED BY
Department of Health and Human Services (HHS)
APPLICANT(S) William Trenkle (Bethesda, Maryland);  Adrian Wiestner (Bethesda, Maryland);  Qiuyan Wang (Bethesda, Maryland);  Yihong Ye (Germantown, Maryland);  Helena Mora-Jensen (Copenhagen, Denmark)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Department of Health and Human Services (Washington, District of Columbia)
INVENTOR(S) William Trenkle (Bethesda, Maryland);  Adrian Wiestner (Bethesda, Maryland);  Qiuyan Wang (Bethesda, Maryland);  Yihong Ye (Germantown, Maryland);  Helena Mora-Jensen (Copenhagen, Denmark)
ABSTRACT The present invention features imidazolidinone compounds and pharmaceutical compositions of imidazolidinone compounds. The compounds of the invention are utilized in methods of treating a deubiquitination-related disorder in a subject and inhibiting p97-associated deubiquitination.
FILED Friday, July 18, 2008
APPL NO 12/669361
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/386
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637565 Fenical et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) William Fenical (Del Mar, California);  Paul Jensen (San Diego, California);  Tracy Mincer (San Diego, California);  Robert H.R. Feling (Wiesbaden, Germany)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) William Fenical (Del Mar, California);  Paul Jensen (San Diego, California);  Tracy Mincer (San Diego, California);  Robert H.R. Feling (Wiesbaden, Germany)
ABSTRACT The present invention is based on the discovery that certain fermentation products of the marine actinomycete strains CNB392 and CNB476 are effective inhibitors of hyperproliferative mammalian cells. The CNB392 and CNB476 strains lie within the family Micromonosporaceae, and the generic epithet Salinospora has been proposed for this obligate marine group. The reaction products produced by this strain are classified as salinosporamides, and are particularly advantageous in treating neoplastic disorders due to their low molecular weight, low IC50 values, high pharmaceutical potency, and selectivity for cancer cells over fungi.
FILED Tuesday, May 22, 2012
APPL NO 13/477364
ART UNIT 1626 — Organic Chemistry
CURRENT CPC
Drug, bio-affecting and body treating compositions
514/421
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637635 Zhang et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Lianglin Zhang (La Jolla, California);  Jason A. Hoffman (La Jolla, California);  Erkki Ruoslahti (Buellton, California)
ASSIGNEE(S)
INVENTOR(S) Lianglin Zhang (La Jolla, California);  Jason A. Hoffman (La Jolla, California);  Erkki Ruoslahti (Buellton, California)
ABSTRACT The present invention provides a variety of isolated peptides and peptidomimetics, which can be useful, for example, in constructing the conjugates of the invention or, where the peptide itself has biological activity, in unconjugated form as a therapeutic for treating any of a varirty of cardiovascular diseases as described below. Thus, the present invention provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CRPPR (SEQ ID NO: 1) or a peptidomimetic thereof. The invention further provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CARPAR (SEQ ID NO: 5) or a peptidomimetic thereof, or amino acid sequence CPKRPR (SEQ ID NO: 6) or a peptidomimtic thereof.
FILED Thursday, January 29, 2009
APPL NO 12/322371
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637639 Kobilka et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
National Institute of Neurological Disorders and Stroke (NINDS)
APPLICANT(S) Brian Kobilka (Palo Alto, California);  Daniel Rosenbaum (Burlingame, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Brian Kobilka (Palo Alto, California);  Daniel Rosenbaum (Burlingame, California)
ABSTRACT Certain embodiments provide a method for crystallizing a GPCR. The method may employ a fusion protein comprising: a) a first portion of a G-protein coupled receptor (GPCR), where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR; b) a stable, folded protein insertion; and c) a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions of the GPCR.
FILED Friday, March 30, 2012
APPL NO 13/436709
ART UNIT 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
530/350
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637652 Philibert et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
APPLICANT(S) Robert Philibert (Iowa City, Iowa);  Anup Madan (Bellevue, Washington)
ASSIGNEE(S)
INVENTOR(S) Robert Philibert (Iowa City, Iowa);  Anup Madan (Bellevue, Washington)
ABSTRACT The present invention provides screening kits, compositions, and diagnostic methods for determining whether a subject has a predisposition to, or likelihood of having, a substance use disorder by determining a nucleic acid methylation profile from a biological sample from the subject, wherein a given profile indicates that the subject has a predisposition to a substance use disorder.
FILED Friday, October 28, 2011
APPL NO 13/284425
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Organic compounds
536/23.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637684 Shen et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Ben Shen (Verona, Wisconsin);  Zhong-Yin Zhang (Indianapolis, Indiana)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin);  Indiana University Research and Technology Corporation (Indianapolis, Indiana)
INVENTOR(S) Ben Shen (Verona, Wisconsin);  Zhong-Yin Zhang (Indianapolis, Indiana)
ABSTRACT The present invention relates to tautomycetin (TTN) and analogs thereof. Also provided are methods of using TTN and analogs thereof in the treatment of various diseases relating to SHP2 function.
FILED Thursday, May 05, 2011
APPL NO 13/101612
ART UNIT 1625 — Organic Chemistry
CURRENT CPC
Organic compounds
549/323
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637696 Gellman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Samuel Helmer Gellman (Madison, Wisconsin);  Yonggui Chi (Berkeley, California);  Li Guo (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Samuel Helmer Gellman (Madison, Wisconsin);  Yonggui Chi (Berkeley, California);  Li Guo (Madison, Wisconsin)
ABSTRACT The invention provides novel compounds and methods to carry out organocatalytic Michael additions of aldehydes to nitroethylene catalyzed by a proline derivative to provide α-substituted-γ-nitroaldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96-99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to protected γ2-amino acids, which are essential for systematic conformational studies of γ-peptide foldamers.
FILED Monday, September 17, 2012
APPL NO 13/621553
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 227/02 (20130101)
C07C 269/00 (20130101)
C07C 271/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637817 Krutchinsky et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) The Rockefeller University (New York, New York)
ASSIGNEE(S)
INVENTOR(S) Andrew N. Krutchinsky (New York, New York);  Vadim Sherman (Brooklyn, New York);  Herbert Cohen (New York, New York);  Brian T. Chait (New York, New York)
ABSTRACT An ion trap includes a containment region for containing ions, and a plurality of electrodes positioned on a regular polyhedral structure encompassing the containment region. An electrode is positioned on each vertex of the encompassing structure and at least one of the polygonal surfaces includes additional electrodes configured to form a plurality of quadrupoles on the surface. Alternating RF voltage is applied to the plurality of electrodes, so that directly neighboring electrodes are of equal amplitude and opposite polarity at any point in time. This configuration on the polyhedral structure forms a potential barrier for repelling the ions from each of the regular polygonal surfaces and containing them in the trap. Mass selective filters can be formed from the quadrupoles for parallel mass analysis in different m/z windows. Application of a small DC potential to a plate electrode outside the quadrupoles preferentially depletes single charged ions for enhanced signal-to-noise analysis.
FILED Friday, March 01, 2013
APPL NO 13/782708
ART UNIT 2881 — Optics
CURRENT CPC
Radiant energy
250/293
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637944 Solin et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Washington University (St. Louis, Missouri)
ASSIGNEE(S) Washington University (St. Louis, Missouri)
INVENTOR(S) Stuart A. Solin (St. Louis, Missouri);  Kirk D. Wallace (St. Louis, Missouri);  Samuel A. Wickline (St. Louis, Missouri);  Michael S. Hughes (Wildwood, Missouri)
ABSTRACT Disclosed herein is an apparatus comprising a metal shunt and a planar semiconductor material in electrical contact with the metal shunt, the metal shunt located on a surface of the semiconductor material, thereby defining a semiconductor/metal interface for passing a flow of current between the semiconductor material and the metal shunt in response to an application of an electrical bias to the apparatus, wherein a portion of that semiconductor material surface is not covered by the metal shunt, wherein the semiconductor material and the metal shunt lie in different planes that are substantially parallel planes, the semiconductor/metal interface thereby being parallel to the plane of semiconductor material, and wherein, when under the electrical bias, the semiconductor/metal interface is configured to exhibit a change in resistance thereof in response to a perturbation. Such an apparatus can be used as a sensor and deployed as an array of sensors.
FILED Monday, May 06, 2013
APPL NO 13/888065
ART UNIT 2823 — Semiconductors/Memory
CURRENT CPC
Active solid-state devices
257/414
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638096 Zhang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
APPLICANT(S) Tao Zhang (Stanford, California);  Michael Lustig (Berkeley, California);  John M. Pauly (Stanford, California);  Shreyas S. Vasanawala (Stanford, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Tao Zhang (Stanford, California);  Michael Lustig (Berkeley, California);  John M. Pauly (Stanford, California);  Shreyas S. Vasanawala (Stanford, California)
ABSTRACT A computer implemented method for magnetic resonance imaging is provided. A 3D Fourier Transform acquisition is performed with two phase encode directions, wherein phase code locations are chosen so that a total number of phase encodes is less than a Nyquist rate, and closest distances between phase encode locations takes on a multiplicity of values. Readout signals are received through a multi-channel array of a plurality of receivers. An autocalibrating parallel imaging interpolation is performed and a noise correlation is generated. The noise correlation is used to weight a data consistency term of a compressed sensing iterative reconstruction. An image is created from the autocalibration parallel imaging using the weighted data consistency term. The image is displayed.
FILED Tuesday, October 19, 2010
APPL NO 12/907764
ART UNIT 2858 — Printing/Measuring and Testing
CURRENT CPC
Electricity: Measuring and testing
324/309
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638358 Dabiri et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
APPLICANT(S) Dana Dabiri (Brier, Washington);  Wei-Hsin Tien (Seattle, Washington);  Patrick Kartes (Charlotte, North Carolina);  Toru Yamasaki (Osaka, Japan)
ASSIGNEE(S) University of Washington (Seattle, Washington)
INVENTOR(S) Dana Dabiri (Brier, Washington);  Wei-Hsin Tien (Seattle, Washington);  Patrick Kartes (Charlotte, North Carolina);  Toru Yamasaki (Osaka, Japan)
ABSTRACT Three-Dimensional Defocusing Particle Image Velocimetry (3DDPIV) allows for measurement of three-dimensional velocities within a volume. In the disclosed embodiment, a mask with a plurality of apertures is disposed with a lens between the test section and a color camera. The field-of-view is backlit and the test section is seeded with black particles. This configuration allows for a lower power light source as compared to conventional 3DDPIV. Color-coded particle images are formed on a white background, wherein each of the color images is generated from light that travels through the filters not blocked by the imaged particle, thereby producing a color image that is of a color different from the color of any of the filters. A color space linear transformation is used to allow for accurate identification of each pinhole exposure when the color filters' spectrum does not match those of the 3-CCD color camera.
FILED Thursday, March 18, 2010
APPL NO 12/727167
ART UNIT 2482 — Recording and Compression
CURRENT CPC
Television
348/47
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639311 Giszter
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Simon F. Giszter (Havertown, Pennsylvania)
ASSIGNEE(S) Philadelphia Health and Education Corporation (Philadelphia, Pennsylvania)
INVENTOR(S) Simon F. Giszter (Havertown, Pennsylvania)
ABSTRACT A single sensing probe comprising multiple, spatially separate, sensing sites is utilized to sense neural activity. The sensing probe includes multiple conductors each with multiple sensing sites in a fixed geometric arrangement. The sensing probe is configured to comprise multiple combined sensing sites in polytrode configuration. By appropriately combining the wire groupings at each combined sensing site, activity sensed from a single wire with multiple sensing sites, can be coupled with other wires to unmix signals from the spatially separate sites and leverage the power of combinatorics to maximize total recording bandwidth and single neuron/unit yield per wire and per probe.
FILED Tuesday, December 14, 2010
APPL NO 12/967878
ART UNIT 3739 — Optics
CURRENT CPC
Surgery
6/377
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639329 Brown et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Edgar A. Brown (Decatur, Georgia);  James D. Ross (Decatur, Georgia);  Richard A. Blum (Atlanta, Georgia);  Stephen P. DeWeerth (Decatur, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Edgar A. Brown (Decatur, Georgia);  James D. Ross (Decatur, Georgia);  Richard A. Blum (Atlanta, Georgia);  Stephen P. DeWeerth (Decatur, Georgia)
ABSTRACT Disclosed are apparatus and methods that provide the ability to electrical stimulate a physical system, and actively eliminate interference with signal acquisition (artifacts) that arises from the stimulation. The technique implemented in the circuits and methods for eliminating interference connects a discharge path to a physical interface to the system to remove charge that is built-up during stimulation. By placing the discharge path in a feedback loop that includes a recording preamplifier and AC-coupling circuitry, the physical interface is brought back to its pre-stimulation offset voltage. The disclosed apparatus and methods may be used with piezoelectric transducers, ultrasound devices, optical diodes, and polarizable and non-polarizable electrodes. The disclosed apparatus can be employed in implantable devices, in vitro or in vivo setups with vertebrate and invertebrate neural tissue, muscle fibers, pancreatic islet cells, osteoblasts, osteoclasts, bacteria, algae, fungi, protists, and plants.
FILED Tuesday, August 29, 2006
APPL NO 11/511794
ART UNIT 3736 — Sheet Container Making, Package Making, Receptacles, Shoes, Apparel, and Tool Driving or Impacting
CURRENT CPC
Surgery: Light, thermal, and electrical application
67/11
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639344 Greenberg et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Eye Institute (NEI)
APPLICANT(S) Robert Jay Greenberg (Los Angeles, California);  Neil Hamilton Talbot (Montrose, California);  Jordan Matthew Neysmith (Pasadena, California);  James Singleton Little (Saugus, California);  Brian V. Mech (Stevenson Ranch, California);  Mark Humayun (Glendale, California);  Dilek Guven (Ankara, Turkey);  Anne-Marie de Merlier Ripley (Los Angeles, California)
ASSIGNEE(S) Second Sight Medical Products, Inc. (Sylmar, California)
INVENTOR(S) Robert Jay Greenberg (Los Angeles, California);  Neil Hamilton Talbot (Montrose, California);  Jordan Matthew Neysmith (Pasadena, California);  James Singleton Little (Saugus, California);  Brian V. Mech (Stevenson Ranch, California);  Mark Humayun (Glendale, California);  Dilek Guven (Ankara, Turkey);  Anne-Marie de Merlier Ripley (Los Angeles, California)
ABSTRACT Polymer materials are useful as electrode array bodies for neural stimulation. They are particularly useful for retinal stimulation to create artificial vision, cochlear stimulation to create artificial hearing, or cortical stimulation many purposes. The pressure applied against the retina, or other neural tissue, by an electrode array is critical. Too little pressure causes increased electrical resistance, along with electric field dispersion. Too much pressure may block blood flow. Common flexible circuit fabrication techniques generally require that a flexible circuit electrode array be made flat. Since neural tissue is almost never flat, a flat array will necessarily apply uneven pressure. Further, the edges of a flexible circuit polymer array may be sharp and cut the delicate neural tissue. By applying the right amount of heat to a completed array, a curve can be induced. With a thermoplastic polymer it may be further advantageous to repeatedly heat the flexible circuit in multiple molds, each with a decreasing radius. Further, it is advantageous to add material along the edges. It is further advantageous to provide a fold or twist in the flexible circuit array. Additional material may be added inside and outside the fold to promote a good seal with tissue.
FILED Friday, April 28, 2006
APPL NO 11/413689
ART UNIT 3762 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Surgery: Light, thermal, and electrical application
67/53
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639447 Kim et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Sangtae Kim (San Diego, California);  Nitin Gupta (La Jolla, California);  Pavel A. Pevzner (La Jolla, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Sangtae Kim (San Diego, California);  Nitin Gupta (La Jolla, California);  Pavel A. Pevzner (La Jolla, California)
ABSTRACT A method for identifying peptides using tandem mass spectrometry takes the spectrum for a peptide to be analyzed and uses a scoring function to score a match between the spectrum and each candidate peptide in a peptide database. The scoring function has a value corresponding to a number of fragment peaks in the spectrum that match fragment peaks in a spectrum of the candidate peptide. Using the match scores, a generating function of the spectrum is computed to determine the number of peptide reconstructions at each value of the scoring function. The generating function is then used to determine the number of candidate peptides for each match score and the probability of a peptide having a given match score to the spectrum. A spectral probability can be determined by calculating the total probability of all peptides with scores equal to or larger than the given match score.
FILED Monday, June 02, 2008
APPL NO 12/602481
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Electric Digital Data Processing
G06F 19/12 (20130101)
G06F 19/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639450 Rimm et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Environmental Health Sciences (NIEHS)
APPLICANT(S) David L. Rimm (Branford, Connecticut);  Robert L. Camp (Stamford, Connecticut)
ASSIGNEE(S) Yale University (New Haven, Connecticut)
INVENTOR(S) David L. Rimm (Branford, Connecticut);  Robert L. Camp (Stamford, Connecticut)
ABSTRACT Systems and methods for rapidly analyzing cell containing samples, for example to identify morphology or to localize and quantitate biomarkers are disclosed.
FILED Wednesday, May 02, 2012
APPL NO 13/462595
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/19
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Defense (DOD) 

US 08635916 Loverich et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Jacob Loverich (State Colleg, Pennsylvania);  Stephen J. Wenner (Port Matilda, Pennsylvania);  Jeremy E. Frank (Pine Grove Mills, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Jacob Loverich (State Colleg, Pennsylvania);  Stephen J. Wenner (Port Matilda, Pennsylvania);  Jeremy E. Frank (Pine Grove Mills, Pennsylvania)
ABSTRACT An internal structural monitoring system for a structure that includes a sensor mounted within the structure to measure at least one of strain experienced by the structure and vibration experience by the structure. It includes a first system support mounted and second system support mounted in the structure, where the first system and the second system support are mounted in the structure such that the sensor is between the first system support and the second system support to hold the sensor in position so that the sensor senses at least one of strain and vibration. It includes a wireless communication unit mounted within the structure, the wireless communication unit connected to the sensor to receive data from the sensor and transmit the data to a receiver outside the structure. It includes a power supply mounted within the structure to supply necessary electrical power to the sensor and the communication unit.
FILED Wednesday, July 06, 2011
APPL NO 13/176959
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Measuring and testing
073/768
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08635940 Goldfarb et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) Michael Goldfarb (Nashville, Tennessee);  Xiangrong Shen (Tuscaloosa, Alabama)
ASSIGNEE(S) Vanderbilt University (Nashville, Tennessee)
INVENTOR(S) Michael Goldfarb (Nashville, Tennessee);  Xiangrong Shen (Tuscaloosa, Alabama)
ABSTRACT A solenoid valve including a spool received within a housing. The spool is configured to move to multiple positions within the housing. The housing includes supply ports, exhaust ports, and outlet ports. When the spool is in a specific location, two outlet ports are in fluid communication with each other.
FILED Monday, January 07, 2008
APPL NO 12/811802
ART UNIT 3745 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Motors: Expansible chamber type
091/464
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08635956 Rastegar et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Tank-Automotive and Armaments Command (TACOM)
APPLICANT(S) Jahangir S. Rastegar (Stony Brook, New York);  Carlos M. Pereira (Tannersville, Pennsylvania);  Richard Dratler (Montville, New Jersey)
ASSIGNEE(S) Omnitek Partners LLC (Ronkonkoma, New York)
INVENTOR(S) Jahangir S. Rastegar (Stony Brook, New York);  Carlos M. Pereira (Tannersville, Pennsylvania);  Richard Dratler (Montville, New Jersey)
ABSTRACT A munition including: a power supply having a piezoelectric material for generating power from a vibration upon impact of the munition; a processor operatively connected to the power supply for initiating detonation time-out circuitry to disable detonation of the munition after a predetermined time.
FILED Saturday, March 09, 2013
APPL NO 13/792008
ART UNIT 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Ammunition and explosives
12/210
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08635967 Chang, III et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Peter A. Chang, III (Silver Spring, Maryland);  Wesley M. Wilson (Ijamsville, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretarey of the Navy (Washington, District of Columbia)
INVENTOR(S) Peter A. Chang, III (Silver Spring, Maryland);  Wesley M. Wilson (Ijamsville, Maryland)
ABSTRACT A method and apparatus for reducing mixing between a first water-type and a second water-type and for increasing the efficiency of ballast water exchange procedures on a ship. The apparatus includes a plurality of ballast water tanks, each having an arrangement to reduce water-mixing. Each arrangement includes a horizontal flow restraining box and two anti-mixing brackets. The ballast water tanks are divided into a plurality of compartments including a main compartment. The arrangement to reduce the water-mixing is provided in the main compartment of each tank.
FILED Thursday, July 28, 2011
APPL NO 13/193430
ART UNIT 3617 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Ships
114/125
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636194 Schultz et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Office of Naval Research (ONR)
APPLICANT(S) Jeffrey Patrick Schultz (Blacksburg, Virginia);  Kevin Creehan (Blacksburg, Virginia)
ASSIGNEE(S) Schultz-Creehan Holdings, Inc. (Blacksburg, Virginia)
INVENTOR(S) Jeffrey Patrick Schultz (Blacksburg, Virginia);  Kevin Creehan (Blacksburg, Virginia)
ABSTRACT A low-temperature friction-based coating method termed friction stir fabrication (FSF) is disclosed, in which material is deposited onto a substrate and subsequently stirred into the substrate using friction stir processing to homogenize and refine the microstructure. This solid-state process is capable of depositing coatings, including nanocrystalline aluminum and/or metal matrix composites and the like, onto substrates such as aluminum at relatively low temperatures. A method of making rod stock for use in the FSF process is also disclosed.
FILED Wednesday, June 02, 2010
APPL NO 12/792655
ART UNIT 1735 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Metal fusion bonding
228/112.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636250 Toni et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Darryl M. Toni (Madison, Connecticut);  Mary McCarthy (Milford, Connecticut);  Bruce H. Barr (Huntington, Connecticut);  Anthony Z. Stobiecki (Shelton, Connecticut);  Thomas Swift (Monroe, Connecticut);  Thomas Dziekonski (Milford, Connecticut)
ASSIGNEE(S) Sikorsky Aircraft Corporation (Stratford, Connecticut)
INVENTOR(S) Darryl M. Toni (Madison, Connecticut);  Mary McCarthy (Milford, Connecticut);  Bruce H. Barr (Huntington, Connecticut);  Anthony Z. Stobiecki (Shelton, Connecticut);  Thomas Swift (Monroe, Connecticut);  Thomas Dziekonski (Milford, Connecticut)
ABSTRACT An external hook system for a rotary-wing aircraft includes a lower frame interface which accommodates longitudinal and lateral loads and an upper frame interface. A tension member is mountable between the lower frame interface and the upper frame interface to transfer tension loads between the lower frame interface and the upper frame interface.
FILED Monday, March 08, 2010
APPL NO 13/258545
ART UNIT 3644 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Aeronautics and astronautics
244/118.200
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636496 Das et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Suman Das (Atlanta, Georgia);  John W. Halloran (Ann Arbor, Michigan)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia);  The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Suman Das (Atlanta, Georgia);  John W. Halloran (Ann Arbor, Michigan)
ABSTRACT Systems and methods for fabricating three-dimensional objects. The system includes an optical imaging system providing a light source; a photosensitive medium adapted to change states upon exposure to a portion of the light source from the optical imaging system; a control system for controlling movement of the optical imaging system, wherein the optical imaging system moves continuously above the photosensitive medium. The method includes moving a maskless optical imaging system providing the light beam in a continuous sequence; presenting the light beam on a portion of the photosensitive medium; lowering a plate upon which the photosensitive medium resides; and applying a new layer of the photosensitive medium.
FILED Tuesday, May 05, 2009
APPL NO 12/435776
ART UNIT 1743 — Tires, Adhesive Bonding, Glass/Paper making, Plastics Shaping & Molding
CURRENT CPC
Plastic article or earthenware shaping or treating: Apparatus
425/174.400
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636721 Alam et al.
FUNDED BY
Department of Defense (DOD)
Uniformed Services University of the Health Sciences (USUHS)
Henry M Jackson Foundation for the Advancement of Military Medicine, Inc (HJF)
APPLICANT(S) Hasan Alam (Germantown, Maryland);  Peter Rhee (San Gabriel, California);  Emily Rhee (San Gabriel, California)
ASSIGNEE(S) Henry M. Jackson Foundation For The Advancement of Military Medicine, Inc. (Rockville, Maryland)
INVENTOR(S) Hasan Alam (Germantown, Maryland);  Peter Rhee (San Gabriel, California);  Emily Rhee (San Gabriel, California)
ABSTRACT A manually operable pump for the effective removal of fluids to include blood, blood clots, fluid, and air from a body cavity of a subject is provided. The manually operable pump is adapted to be connect to a range of fluid conduits and is equipped with one-way valves that effectively permit flow of fluid through the pump in only one direction. The sensitivity of the one-way valves is such that when properly positioned, fluid can flow through the valves and out of the pump without manual compression of the pump and with the aid of gravity power alone.
FILED Monday, November 22, 2004
APPL NO 10/595450
ART UNIT 3761 — Refrigeration, Vaporization, Ventilation, and Combustion
CURRENT CPC
Surgery
64/541
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636860 DiSalvo et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Roberto DiSalvo (Madison, Alabama);  H. Waite Dykes, Jr. (Huntsville, Alabama);  Robin D. Rogers (Tuscaloosa, Alabama);  Julia Shamshina (Tuscaloosa, Alabama);  Marcin Smiglak (Bad Friedrichshall, Germany)
ASSIGNEE(S) Streamline Automation, LLC (Huntsville, Alabama);  The University of Alabama (Tuscaloosa, Alabama)
INVENTOR(S) Roberto DiSalvo (Madison, Alabama);  H. Waite Dykes, Jr. (Huntsville, Alabama);  Robin D. Rogers (Tuscaloosa, Alabama);  Julia Shamshina (Tuscaloosa, Alabama);  Marcin Smiglak (Bad Friedrichshall, Germany)
ABSTRACT An energetic ionic liquid catalytic decomposition gas generator uses stoichiometric and nonstoiciometric mixtures of specific energetic ionic liquids and iridium catalyst. The catalyst temperature used and gas production versus ignition may be controlled by combining one or more cationic species with one or more anionic species of the ionic liquid(s).
FILED Wednesday, December 01, 2010
APPL NO 12/958022
ART UNIT 1734 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Explosive and thermic compositions or charges
149/1
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636861 Stec, III et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Daniel Stec, III (Long Valley, New Jersey);  Amy Wilson (Blairstown, New Jersey);  Brian E. Fuchs (Hackettstown, New Jersey);  Neha Mehta (Succasunna, New Jersey);  Paula Cook (Succasunna, New Jersey)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Daniel Stec, III (Long Valley, New Jersey);  Amy Wilson (Blairstown, New Jersey);  Brian E. Fuchs (Hackettstown, New Jersey);  Neha Mehta (Succasunna, New Jersey);  Paula Cook (Succasunna, New Jersey)
ABSTRACT Secondary crystalline high explosives are disclosed which are suitable for filling very small volume loading holes in micro-electric initiators for micro-electro-mechanical mechanisms (MEMS), used as safe and arm (S&A) devices. The explosives are prepared by adding the such a high explosive to an aqueous first volatile mobile phase, adding such a high explosive to a non-aqueous second volatile mobile phase, mixing the first and second volatile mobile phases and then loading the combined phases into the MEMS device and allowing the aqueous and non-aqueous solvents to evaporate depositing the high explosive. Enhanced adhesion between the deposited high explosive and enhanced rheological properties can be obtained by adding a polymeric binder to both mobile phases.
FILED Wednesday, December 29, 2010
APPL NO 12/980571
ART UNIT 1734 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Explosive and thermic compositions or charges
149/92
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637013 Liu et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
APPLICANT(S) Yang Liu (Ann Arbor, Michigan);  Pan Zheng (Ann Arbor, Michigan);  Guo-Yun Chen (Ann Arbor, Michigan);  Xincheng Zheng (Ann Arbor, Michigan);  Xi Cheng (Woodland, California);  Steve Kunkel (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of The University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Yang Liu (Ann Arbor, Michigan);  Pan Zheng (Ann Arbor, Michigan);  Guo-Yun Chen (Ann Arbor, Michigan);  Xincheng Zheng (Ann Arbor, Michigan);  Xi Cheng (Woodland, California);  Steve Kunkel (Ann Arbor, Michigan)
ABSTRACT The present technology provides methods and compositions for the treatment of tissue-damage related immune dysregulation by administering a composition comprising one or more of CD24; CD24 fragments, variants and derivatives, CD24Fc fusion proteins; HMBG1-binding proteins, binding proteins to HMBG1 Box B; antagonists of HMGB1, polyclonal, monoclonal, recombinant, chimeric, humanized scFv antibodies and antibody fragments to HMGB1 or fragments of HMGB1 and antibodies that bind and suppress the activity of HMGB1 Box B; Siglec 10 agonists such as anti-Siglec 10 antibodies; and combinations thereof to a patient.
FILED Wednesday, March 21, 2012
APPL NO 13/426392
ART UNIT 1644 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/130.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637041 Guerry-Kopecko et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Patricia Guerry-Kopecko (Silver Spring, Maryland);  Shahida Baqar (Olney, Maryland)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Patricia Guerry-Kopecko (Silver Spring, Maryland);  Shahida Baqar (Olney, Maryland)
ABSTRACT The invention relates to an immunogenic composition composed of secreted polypeptides derived from Campylobacter jejuni non-flagellar proteins that are coordinately expressed with the flagellar regulon. The invention also relates to a method of inducing an immune response to the non-flagellar protein polypeptides.
FILED Tuesday, June 19, 2012
APPL NO 13/526610
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/185.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637137 Joseph et al.
FUNDED BY
Department of Defense (DOD)
Missile Defense Agency (MDA)
National Science Foundation (NSF)
APPLICANT(S) Paul Jayachandran Joseph (Atlanta, Georgia);  Paul A. Kohl (Atlanta, Georgia);  Sue Ann Bidstrup Allen (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Paul Jayachandran Joseph (Atlanta, Georgia);  Paul A. Kohl (Atlanta, Georgia);  Sue Ann Bidstrup Allen (Atlanta, Georgia)
ABSTRACT Microstructures and methods of fabricating microstructures are disclosed. One exemplary microstructure, among others, includes a substrate, an overcoat layer disposed upon the substrate, an air-region within at least a portion of the overcoat layer, and a framing material layer engaging at least a portion of the air-region on the inside of the framing material layer and engaging the overcoat layer on the outside of the framing material layer.
FILED Thursday, January 25, 2007
APPL NO 11/657769
ART UNIT 1783 — Miscellaneous Articles, Stock Material
CURRENT CPC
Stock material or miscellaneous articles
428/161
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637162 Zabinski
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
APPLICANT(S) Jeffrey S. Zabinski (Yellow Springs, Ohio)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia)
INVENTOR(S) Jeffrey S. Zabinski (Yellow Springs, Ohio)
ABSTRACT A method and class of bond coat is provided that physically and chemically bonds solid layer lubricants and other functional coatings to a substrate by burnishing, for example, selected soft materials, including oxides such as antimony trioxide, against the substrate. The new method and bond coat is a major improvement over conventional bonding or coating methods. The process is non-vacuum at ambient temperatures, requiring no binders, adhesives, curing or baking. Lubricant performance can be enhanced by orders of magnitude compared to when the bond coat and burnishing process are not applied. The method is inexpensive, environmentally friendly, applicable to any substrate material, and scalable.
FILED Tuesday, March 31, 2009
APPL NO 12/741282
ART UNIT 1784 — Miscellaneous Articles, Stock Material
CURRENT CPC
Stock material or miscellaneous articles
428/615
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637231 Van Dyke
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Mark E. Van Dyke (Winston Salem, North Carolina)
ASSIGNEE(S) Wake Forest University Health Sciences (Winston-Salem, North Carolina)
INVENTOR(S) Mark E. Van Dyke (Winston Salem, North Carolina)
ABSTRACT A liquid plasma expander or resuscitation fluid composition for use in a subject in need thereof, comprising, consisting of, or consisting essentially of: (a) a keratin derivative (preferably alpha keratose, gamma keratose, or combinations thereof, and with basic alpha keratose preferred over acidic alpha keratose); and (b) an electrolyte solution, with the keratin derivative solubilized in the electrolyte solution to form a homogeneous liquid composition. Blood substitutes formed therefrom and methods of making and using the same are also described.
FILED Thursday, August 11, 2011
APPL NO 13/207992
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/1.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637265 Navari et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
U.S. Army Medical Research and Materiel Command (USAMRMC)
APPLICANT(S) Rudolph M. Navari (Granger, Indiana);  Mary Prorok (South Bend, Indiana);  Francis J. Castellino (Granger, Indiana)
ASSIGNEE(S) University of Notre Dame (Notre Dame, Indiana)
INVENTOR(S) Rudolph M. Navari (Granger, Indiana);  Mary Prorok (South Bend, Indiana);  Francis J. Castellino (Granger, Indiana)
ABSTRACT Elevated levels of cathepsin E (catE) are demonstrated to be diagnostic of intestinal forms of cancer, such as colorectal cancer. Elevated levels of cathepsin E (catE, monomeric forms) are demonstrated to be detectable in the urine of animals having colorectal cancer, and a diagnostic/screening method for identifying and/or detecting colorectal cancer in an animal from a urine sample is provided. Specific tissue immunohistochemcial staining for catE (monomeric forms) in dysplastic tissue is also disclosed, and is shown to correlate with the level of dysplastic lesion severity. Hence, a method for identifying and determining the level of dysplastic lesion severity is provided. Cathepsin E mRNA transcription and expression levels are also demonstrated to be upregulated in dysplastic tissue, relative to non-dysplastic tissue. Hence, a method for transcriptionally profiling an animal to monitor the progression of colorectal disease is provided.
FILED Tuesday, December 28, 2010
APPL NO 12/979889
ART UNIT 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/7.230
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637267 Keiler et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Defense Threat Reduction Agency (DTRA)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
APPLICANT(S) Kenneth C. Keiler (Boalsburg, Pennsylvania);  Stephen J. Benkovic (State College, Pennsylvania)
ASSIGNEE(S) The Penn State Research Foundation (University Park, Pennsylvania)
INVENTOR(S) Kenneth C. Keiler (Boalsburg, Pennsylvania);  Stephen J. Benkovic (State College, Pennsylvania)
ABSTRACT Inhibitors of the tmRNA pathway have antibacterial activity with broad species specificity, including B. anthracis and other pathogens of military and civilian interest. Identified cyclic or linear peptides are further selected by in vivo selection methods, kill bacterial pathogens when added exogenously, and/or eliminate plasmids carrying antibiotic resistance or virulence genes. The molecular target of each cyclic peptide is in the tmRNA pathway and the tmRNA pathway is inhibited in vitro and in vivo by the addition of the peptides.
FILED Monday, April 28, 2008
APPL NO 12/111096
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/8
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637270 Kidwell
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) David A Kidwell (Alexandria, Virginia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) David A Kidwell (Alexandria, Virginia)
ABSTRACT The present invention is generally directed to a fluidized bed detector for continuous detection of biological and chemical materials comprising a fluidized bed of detecting elements suspended in a continuous flow system wherein the detecting elements remain in the system when a first force trying to move the detecting elements to the bottom of the system is balanced with a second opposing force of a flowing gas or liquid trying to move detecting elements to the top of the system and wherein the presence of a target molecule in the flowing gas or liquid disrupts the balance of the first and second forces causing the detecting element to exit the system. The release of the detecting element indicates the presence of the target molecule and may be captured, concentrated, or both for further evaluation by other assays or other means. Also disclosed is the related method of detecting biological and chemical materials using a fluidized bed detector.
FILED Friday, November 13, 2009
APPL NO 12/618180
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/29
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637303 Lapota et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Space and Naval Warfare Systems Center (SPAWAR)
APPLICANT(S) David Lapota (San Diego, California);  Bryan Travis Bjorndal (Carlsbad, California);  Gregory Wayne Anderson (San Diego, California)
ASSIGNEE(S) United States of America as represented by Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) David Lapota (San Diego, California);  Bryan Travis Bjorndal (Carlsbad, California);  Gregory Wayne Anderson (San Diego, California)
ABSTRACT A system for assessing the characteristics and toxicity of a water sample comprising: a test chamber; an optical signal generator configured to emit an optical signal into the test chamber; a first digital filter disposed between the optical signal generator and the test chamber; a first optical transducer disposed to generate a first data signal in response to detecting radiant energy in the test chamber; a second digital filter disposed between the first optical transducer and the test chamber; an aqueous suspension of dinoflagellates contained within the test chamber and mixed with the water sample; a stimulator disposed to stimulate the dinoflagellates to emit a bioluminescence signal; and a microprocessor operatively coupled to the optical signal generator, the first digital optical filter, the stimulator, the first optical transducer, and the second digital filter, wherein the microprocessor is configured to assess the spectral characteristics and toxicity of the water sample.
FILED Thursday, May 12, 2011
APPL NO 13/106695
ART UNIT 1775 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/288.700
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637344 Kummel et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Andrew C. Kummel (San Diego, California);  Jeongwon Park (Palo Alto, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Andrew C. Kummel (San Diego, California);  Jeongwon Park (Palo Alto, California)
ABSTRACT A method for forming a thin film electrode for an organic thin film transistor of the invention provides a multi-layer mask on a substrate with an electrode area opening in a top layer of the mask that is undercut by openings in other layers of the mask. A thin film of metal is deposited in the electrode area on the substrate. Removing the multi-layer mask leaves a well-formed thin film electrode with naturally tapered edges. A preferred embodiment of the invention is a method for forming a thin film electrode for an organic thin film transistor. The method includes depositing a first layer of photoresist on a substrate. The photoresist of the first layer has a first etching rate. A second layer of photoresist is deposited on the first layer of photoresist. The photoresist of the second layer has a second etching rate that is lower than the first etching rate. The first and second layer of photoresist are patterned by exposure. Developing the first and second layers of photoresist provides an electrode area on the substrate. An electrode is deposited in the electrode area. Lift-off of the first and second layers is performed. The electrode that is deposited has a tailored, tapered edge. A preferred embodiment thin film electrode in an organic thin film transistor has a tapered edge with a contact angle of approximately +40±4.4°.
FILED Tuesday, April 21, 2009
APPL NO 12/936586
ART UNIT 2815 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/99
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637361 Appenzeller et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Joerg Appenzeller (Valhalla, New York);  Supratik Guha (Chappaqua, New York);  Emanuel Tutuc (Yorktown Heights, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Joerg Appenzeller (Valhalla, New York);  Supratik Guha (Chappaqua, New York);  Emanuel Tutuc (Yorktown Heights, New York)
ABSTRACT A semiconductor structure is provided, which includes multiple sections arranged along a longitudinal axis. Preferably, the semiconductor structure comprises a middle section and two terminal sections located at opposite ends of the middle section. A semiconductor core having a first dopant concentration preferably extends along the longitudinal axis through the middle section and the two terminal sections. A semiconductor shell having a second, higher dopant concentration preferably encircles a portion of the semiconductor core at the two terminal sections, but not at the middle section, of the semiconductor structure. It is particularly preferred that the semiconductor structure is a nanostructure having a cross-sectional dimension of not more than 100 nm.
FILED Monday, March 07, 2011
APPL NO 13/041740
ART UNIT 2893 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/197
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637386 Zhang et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Qingchun Zhang (Cary, North Carolina);  Anant K. Agarwal (Chapel Hill, North Carolina);  Tangali S. Sudarshan (Columbia, South Carolina);  Alexander Bolotnikov (Niskayuna, New York)
ASSIGNEE(S) Cree, Inc. (Durham, North Carolina)
INVENTOR(S) Qingchun Zhang (Cary, North Carolina);  Anant K. Agarwal (Chapel Hill, North Carolina);  Tangali S. Sudarshan (Columbia, South Carolina);  Alexander Bolotnikov (Niskayuna, New York)
ABSTRACT An electronic device includes a silicon carbide layer having a first conductivity type and a main junction adjacent a surface of the silicon carbide layer, and a junction termination region at the surface of the silicon carbide layer adjacent the main junction. Charge in the junction termination region decreases with lateral distance from the main junction, and a maximum charge in the junction termination region may be less than about 2×1014 cm−2.
FILED Monday, March 08, 2010
APPL NO 12/719497
ART UNIT 2813 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/558
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637635 Zhang et al.
FUNDED BY
Department of Defense (DOD)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
APPLICANT(S) Lianglin Zhang (La Jolla, California);  Jason A. Hoffman (La Jolla, California);  Erkki Ruoslahti (Buellton, California)
ASSIGNEE(S)
INVENTOR(S) Lianglin Zhang (La Jolla, California);  Jason A. Hoffman (La Jolla, California);  Erkki Ruoslahti (Buellton, California)
ABSTRACT The present invention provides a variety of isolated peptides and peptidomimetics, which can be useful, for example, in constructing the conjugates of the invention or, where the peptide itself has biological activity, in unconjugated form as a therapeutic for treating any of a varirty of cardiovascular diseases as described below. Thus, the present invention provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CRPPR (SEQ ID NO: 1) or a peptidomimetic thereof. The invention further provides an isolated peptide or peptidomimetic which has a length of less than 60 residues and includes the amino acid sequence CARPAR (SEQ ID NO: 5) or a peptidomimetic thereof, or amino acid sequence CPKRPR (SEQ ID NO: 6) or a peptidomimtic thereof.
FILED Thursday, January 29, 2009
APPL NO 12/322371
ART UNIT 1658 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Preparations for Medical, Dental, or Toilet Purposes
A61K 38/04 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637848 Preble et al.
FUNDED BY
Department of Defense (DOD)
Missile Defense Agency (MDA)
APPLICANT(S) Kyma Technologies, Inc. (Raleigh, North Carolina)
ASSIGNEE(S) Kyma Technologies, Inc. (Raleigh, North Carolina)
INVENTOR(S) Edward Preble (Raleigh, North Carolina);  Lianghong Liu (Raleigh, North Carolina);  Andrew D. Hanser (Saint Paul, Minnesota);  N. Mark Williams (Raleigh, North Carolina);  Xueping Xu (Stamford, Connecticut)
ABSTRACT In a method for making a GaN article, an epitaxial nitride layer is deposited on a single-crystal substrate. A 3D nucleation GaN layer is grown on the epitaxial nitride layer by HVPE under a substantially 3D growth mode. A GaN transitional layer is grown on the 3D nucleation layer by HVPE under a condition that changes the growth mode from the substantially 3D growth mode to a substantially 2D growth mode. A bulk GaN layer is grown on the transitional layer by HVPE under the substantially 2D growth mode. A polycrystalline GaN layer is grown on the bulk GaN layer to form a GaN/substrate bi-layer. The GaN/substrate bi-layer may be cooled from the growth temperature to an ambient temperature, wherein GaN material cracks laterally and separates from the substrate, forming a free-standing article.
FILED Thursday, December 06, 2012
APPL NO 13/706920
ART UNIT 2829 — Semiconductors/Memory
CURRENT CPC
Active solid-state devices
257/21
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637875 Finkelstein et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
APPLICANT(S) Hod Finkelstein (El Cerrito, California);  Sadik C. Esener (Solana Beach, California);  Yu-Hwa Lo (San Diego, California);  Kai Zhao (Fishkill, New York);  James Cheng (La Jolla, California);  Sifang You (La Jolla, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Hod Finkelstein (El Cerrito, California);  Sadik C. Esener (Solana Beach, California);  Yu-Hwa Lo (San Diego, California);  Kai Zhao (Fishkill, New York);  James Cheng (La Jolla, California);  Sifang You (La Jolla, California)
ABSTRACT Apparatuses and systems for photon detection can include a first optical sensing structure structured to absorb light at a first optical wavelength; and a second optical sensing structure engaged with the first optical sensing structure to allow optical communication between the first and the second optical sensing structures. The second optical sensing structure can be structured to absorb light at a second optical wavelength longer than the first optical wavelength and to emit light at the first optical wavelength which is absorbed by the first optical sensing structure. Apparatuses and systems can include a bandgap grading region.
FILED Monday, July 13, 2009
APPL NO 12/502225
ART UNIT 2893 — Semiconductors/Memory
CURRENT CPC
Active solid-state devices
257/84
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637901 Zheleva et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Tsvetanka Zheleva (Rockville, Maryland);  Shah Pankaj (Rockville, Maryland);  Michael Derenge (Columbia, Maryland)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Army (Washington, District of Columbia)
INVENTOR(S) Tsvetanka Zheleva (Rockville, Maryland);  Shah Pankaj (Rockville, Maryland);  Michael Derenge (Columbia, Maryland)
ABSTRACT A low-defect gallium nitride structure including a first gallium nitride layer comprising a plurality of gallium nitride columns etched into the first gallium nitride layer and a first dislocation density; and a second gallium nitride layer that extends over the gallium nitride columns and comprises a second dislocation density, wherein the second dislocation density may be lower than the first dislocation density. In addition, a method for fabricating a gallium nitride semiconductor layer that includes masking an underlying gallium nitride layer with a mask that comprises an array of columns and growing the underlying gallium nitride layer through the columns and onto said mask using metal-organic chemical vapor deposition pendeo-epitaxy to thereby form a pendeo-epitaxial gallium nitride layer coalesced on said mask to form a continuous pendeo-epitaxial monocrystalline gallium nitride semiconductor layer.
FILED Tuesday, August 07, 2012
APPL NO 13/568362
ART UNIT 2891 — Semiconductors/Memory
CURRENT CPC
Active solid-state devices
257/189
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638011 Robinson et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
Combat Capabilities Development Command (CCDC)
Army Research Laboratory (CCDC ARL)
Research, Development and Engineering Command (RDECOM)
APPLICANT(S) Philip T. Robinson (Harvard, Massachusetts);  Seth M. Dziengeleski (Southbridge, Massachusetts);  James D. Kazmierczak (Marlborough, Massachusetts);  David J. Holigan (Atkinson, New Hampshire)
ASSIGNEE(S) Protonex Technology Corporation (Southborough, Massachusetts)
INVENTOR(S) Philip T. Robinson (Harvard, Massachusetts);  Seth M. Dziengeleski (Southbridge, Massachusetts);  James D. Kazmierczak (Marlborough, Massachusetts);  David J. Holigan (Atkinson, New Hampshire)
ABSTRACT Various aspects of invention provide portable power manager operating methods. One aspect of the invention provides a method for operating a power manager having a plurality of device ports for connecting with external power devices and a power bus for connecting with each device port. The method includes: disconnecting each device port from the power bus when no external power device is connected to the device port; accessing information from newly connected external power devices; determining if the newly connected external power devices can be connected to the power bus without power conversion; if not, determining if the newly connected external power devices can be connected to the power bus over an available power converter; and if so, configuring the available power converter for suitable power conversion.
FILED Tuesday, June 15, 2010
APPL NO 12/816080
ART UNIT 2836 — Electrical Circuits and Systems
CURRENT CPC
Electrical transmission or interconnection systems
37/115
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638217 Arms et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Steven W. Arms (Williston, Vermont);  Chris Pruyn Townsend (Shelburne, Vermont);  David Lawrence Churchill (Burlington, Vermont);  Michael John Hamel (Essex Junction, Vermont)
ASSIGNEE(S) Lord Corporation (Cary, North Carolina)
INVENTOR(S) Steven W. Arms (Williston, Vermont);  Chris Pruyn Townsend (Shelburne, Vermont);  David Lawrence Churchill (Burlington, Vermont);  Michael John Hamel (Essex Junction, Vermont)
ABSTRACT A system comprises a sensing node that includes a sensor, a processor, an energy harvesting circuit, a time keeper, a first energy storage device, and a second energy storage device. The energy harvesting circuit is connected for recharging the first energy storage device. The processor is connected for receiving all its power derived from the energy harvesting circuit. The second energy storage device is connected for powering the time keeper.
FILED Friday, March 12, 2010
APPL NO 12/723284
ART UNIT 2687 — Dynamic Storage Systems; Mechanical parts of Disk Drives
CURRENT CPC
Communications: Electrical
340/539.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638587 De Brosse et al.
FUNDED BY
Department of Defense (DOD)
APPLICANT(S) International Business Machines Corporation (Armonk, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) John K. De Brosse (Colchester, Vermont);  William J. Gallagher (Ardsley, New York);  Yu Lu (Ridgefield, Connecticut)
ABSTRACT In one embodiment, the invention is a magnetic shift register memory device. One embodiment of a memory cell includes a magnetic column including a plurality of magnetic domains, a reader coupled to the magnetic column, for reading data from the magnetic domains, a temporary memory for storing data read from the magnetic domains, and a writer coupled to the magnetic column, for writing data in the temporary memory to the magnetic domains.
FILED Friday, August 02, 2013
APPL NO 13/957937
ART UNIT 2824 — Semiconductors/Memory
CURRENT CPC
Static information storage and retrieval
365/81
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638890 Kumar
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
The Aerospace Corporation (AEROSPACE)
Federally Funded Research and Development Center (FFRDC)
Operated by The Aerospace Corporation (AEROSPACE) at El Segundo, CA
APPLICANT(S) Rajendra Kumar (Cerritos, California)
ASSIGNEE(S) The Aerospace Corporation (El Segundo, California)
INVENTOR(S) Rajendra Kumar (Cerritos, California)
ABSTRACT A receiver may comprise a complex mixer for converting the modulated signal to a complex modulated signal comprising a first in-phase component and a first quadrature component. The receiver may further comprise a digital demodulator. The digital demodulator may comprise at least one processor circuit programmed for applying a phase differencer for generating an output function in terms of a phase difference of the complex modulated signal. Applying the phase differencer may comprise converting the first in-phase component to a function of a phase difference of the first in-phase component expressed in digital time, and converting the first quadrature component to a function of the phase difference of the first quadrature component expressed in digital time. The at least one processor circuit of the digital demodulator may also be programmed for applying a four quadrant inverse tangent to the output function to generate the information signal.
FILED Monday, May 07, 2012
APPL NO 13/465606
ART UNIT 2633 — Digital Communications
CURRENT CPC
Pulse or digital communications
375/346
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638963 Parkins
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) John W. Parkins (Ithaca, New York)
ASSIGNEE(S) Red Tail Hawk Corporation (Ithaca, New York)
INVENTOR(S) John W. Parkins (Ithaca, New York)
ABSTRACT A hearing protection system with talk-through having a pair of rigid earcups enclosing a microphone, amplifier and speaker. A concha simulator, having a volume simulating that of the concha of a human ear, is acoustically coupled to the microphone, and also to the outside through an opening in the earcup. By coupling the microphone to the concha simulator, instead of directly to the outside, the acoustic response of the talk-through more accurately represents the hearing of a user.
FILED Friday, May 28, 2010
APPL NO 12/789942
ART UNIT 2832 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Electrical audio signal processing systems and devices
381/322
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639055 Hou et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Weilin Hou (Slidell, Louisiana);  Alan D. Weidemann (Carriere, Mississippi)
ASSIGNEE(S) The United States of America, as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Weilin Hou (Slidell, Louisiana);  Alan D. Weidemann (Carriere, Mississippi)
ABSTRACT A method for calculating an image quality metric for evaluating the quality of a digital image including the steps of denoising the data of the image, identifying edges in the denoised data, determining an edge profile of the edges, determining a grayscale angle for each identified edge in the edge profile that is associated with the edge, and calculating the image quality metric based on a weighted average of the grayscale angles for all the edges.
FILED Thursday, April 04, 2013
APPL NO 13/856487
ART UNIT 2667 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image analysis
382/266
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639065 Feng et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Ning-Ning Feng (Arcadia, California);  Shirong Liao (Mira Loma, California);  Dawei Zheng (Arcadia, California);  Dazeng Feng (El Monte, California)
ASSIGNEE(S) Kotura, Inc. (Monterey Park, California)
INVENTOR(S) Ning-Ning Feng (Arcadia, California);  Shirong Liao (Mira Loma, California);  Dawei Zheng (Arcadia, California);  Dazeng Feng (El Monte, California)
ABSTRACT The system includes a light-transmitting medium positioned on a base. The light-transmitting medium included a ridge and a slab region. The ridge extends upward from the slab region and defines a portion of a waveguide on the base. The waveguide is configured to guide a light signal through the device. The device also includes an avalanche effect light sensor positioned on the base and configured to detect the presence of the light signal. The light sensor includes a light-absorbing medium positioned on the ridge of the light-transmitting medium such that the light signal is coupled from the light-transmitting medium into the light-absorbing medium. The light-transmitting includes a charge layer located at an interface of the light-transmitting medium and the light-absorbing medium. A multiplication region is formed in the slab regions of the light-transmitting medium such that the multiplication region receives charge carriers from the charge layer during the operation of the light sensor.
FILED Friday, June 18, 2010
APPL NO 12/803136
ART UNIT 2883 — Optics
CURRENT CPC
Optical waveguides
385/12
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639312 Clark et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Department of the Navy (DON)
APPLICANT(S) Gregory Arthur Clark (Salt Lake City, Utah);  David J. Warren (Salt Lake City, Utah);  Noah M. Ledbetter (Salt Lake City, Utah)
ASSIGNEE(S) University of Utah Research Foundation (Salt Lake City, Utah)
INVENTOR(S) Gregory Arthur Clark (Salt Lake City, Utah);  David J. Warren (Salt Lake City, Utah);  Noah M. Ledbetter (Salt Lake City, Utah)
ABSTRACT A system and method for electrically shielding a physiological pathway from electrical noise is disclosed. The method includes the operation of implanting at least one signal microelectrode into a patient such that the signal microelectrode is proximate to the physiological pathway. An additional operation includes substantially enclosing the microelectrode and a section of the physiological pathway with an electrical shielding wrap. The electrical shielding wrap includes a plurality of holes that enable fluid communication of physiological fluids between an inside and outside of the wrap.
FILED Thursday, December 10, 2009
APPL NO 12/635374
ART UNIT 3766 — Optics
CURRENT CPC
Surgery
6/378
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639453 Qing et al.
FUNDED BY
Department of Defense (DOD)
Department of the Army (DOA)
APPLICANT(S) Xinlin Qing (Cupertino, California);  Irene J. Li (Stanford, California);  Chang Zhang (Santa Clara, California)
ASSIGNEE(S) Acellent Technologies, Inc. (Sunnyvale, California)
INVENTOR(S) Xinlin Qing (Cupertino, California);  Irene J. Li (Stanford, California);  Chang Zhang (Santa Clara, California)
ABSTRACT A self-sufficient structural health monitoring system that can monitor a structure without need for external power input. Embodiments of the invention provide a structural health monitoring system with a power supply integrated within, so that the system relies on itself for operational power. Systems with such an on-board electrical power source, independent of an external power source (and in particular, independent of the power system(s) of the structure being monitored), are much more self-contained and self-sufficient.
FILED Wednesday, November 25, 2009
APPL NO 12/626594
ART UNIT 2857 — Printing/Measuring and Testing
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/34
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639475 Rikoski
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Richard Rikoski (Alameda, California)
ASSIGNEE(S) The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Richard Rikoski (Alameda, California)
ABSTRACT A system and method of signal detection from a given point, in which a radiative aperture, such as a sonar sensor, radar antenna, acoustic sensor, or the like, receives radiation from the point at more than one range. At each range, the signal incident on each point within the aperture is weighted by the cosine of the angle between a surface normal at the point on the aperture, and a vector from the point on the aperture to the given point. The physical size and shape of the aperture may also be changed to cause the aperture to subtend the same solid angle having the given point as the vertex, at each range. In this manner, the signal from the given point becomes aperture shape independent, facilitating object recognition and imaging.
FILED Monday, May 18, 2009
APPL NO 12/454486
ART UNIT 2857 — Printing/Measuring and Testing
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/189
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639476 Martell et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
APPLICANT(S) Craig A. Martell (Spotsylvania, Virginia);  John A. Lawton (King George, Virginia);  David B. Hurley (Fredericksburg, Virginia)
ASSIGNEE(S) The United States of America as Represented by the Secretary of the Navy (Washington, District of Columbia)
INVENTOR(S) Craig A. Martell (Spotsylvania, Virginia);  John A. Lawton (King George, Virginia);  David B. Hurley (Fredericksburg, Virginia)
ABSTRACT A computer-implemented method is provided for generating the estimation of current position, velocity and acceleration state vectors and associated uncertainty estimation (covariance) of a boosting ballistic missile. The method includes constructing a state tensor of the projectile from a plurality of sensor measurements in Earth-Centered, Earth-Fixed (ECEF) coordinates; translating the state tensor to Cartesian coordinates as a transform state; determining a covariance matrix from the transform state; updating the transformed state as an updated transform state; and updating the covariance matrix as an updated covariance. The process can further include adjusting the covariance matrix by an approximate transition matrix and a process noise matrix. The noise matrix can be translated from a local noise matrix based on a propagation time-step, a scaling parameter, and a bias process noise level. A time-of-flight in the state tensor can be updated by smoothing from a launch event.
FILED Tuesday, January 31, 2012
APPL NO 13/385465
ART UNIT 2864 — Printing/Measuring and Testing
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/196
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639510 Yu et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Kai Yu (Pittsburgh, Pennsylvania);  Rob A. Rutenbar (Pittsburgh, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Kai Yu (Pittsburgh, Pennsylvania);  Rob A. Rutenbar (Pittsburgh, Pennsylvania)
ABSTRACT A hardware acoustic scoring unit for a speech recognition system and a method of operation thereof are provided. Rather than scoring all senones in an acoustic model used for the speech recognition system, acoustic scoring logic first scores a set of ciphones based on acoustic features for one frame of sampled speech. The acoustic scoring logic then scores senones associated with the N highest scored ciphones. In one embodiment, the number (N) is three. While the acoustic scoring logic scores the senones associated with the N highest scored ciphones, high score ciphone identification logic operates in parallel with the acoustic scoring unit to identify one or more additional ciphones that have scores greater than a threshold. Once the acoustic scoring unit finishes scoring the senones for the N highest scored ciphones, the acoustic scoring unit then scores senones associated with the one or more additional ciphones.
FILED Monday, December 22, 2008
APPL NO 12/341160
ART UNIT 2657 — Linguistics, Speech Processing and Audio Compression
CURRENT CPC
Data processing: Speech signal processing, linguistics, language translation, and audio compression/decompression
74/256.600
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639955 Bose et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Pradip Bose (New York, New York);  Alper Buyuktosunoglu (White Plains, New York);  Chen-Yong Cher (Port Chester, New York);  Prabhakar N. Kudva (New York, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Pradip Bose (New York, New York);  Alper Buyuktosunoglu (White Plains, New York);  Chen-Yong Cher (Port Chester, New York);  Prabhakar N. Kudva (New York, New York)
ABSTRACT A system and method for controlling power and performance in a microprocessor system includes a monitoring and control system integrated into a microprocessor system. The monitoring and control system includes a hierarchical architecture having a plurality of layers. Each layer in the hierarchal architecture is responsive to commands from a higher level, and the commands provide instructions on operations and power distribution, such that the higher levels provide modes of operation and budgets to lower levels and the lower levels provide feedback to the higher levels to control and manage power usage in the microprocessor system both globally and locally.
FILED Wednesday, November 09, 2011
APPL NO 13/292712
ART UNIT 2116 — Computer Error Control, Reliability, & Control Systems
CURRENT CPC
Electrical computers and digital processing systems: Support
713/300
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640087 Sabbouh
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Materiel Command (AFMC)
APPLICANT(S) Marwan Sabbouh (Chelmsford, Massachusetts)
ASSIGNEE(S) The MITRE Corporation (McLean, Virginia)
INVENTOR(S) Marwan Sabbouh (Chelmsford, Massachusetts)
ABSTRACT A method and a scripting paradigm for automatically integrating disparate information systems (e.g., web services and databases) within a given enterprise into a service-oriented architecture. A script writer generates a script using a scripting paradigm, and the resulting script automatically derives new data models, new ontological structures, new mappings, and a new web service that integrates disparate information systems. In addition to integrating disparate information systems, the scripts may be harvested to automate the metadata discovery and retrieval process. The scripting paradigm builds upon existing open-source scripting languages and is compatible with existing internet browsers, thus encouraging mass participation in the integration process.
FILED Friday, December 07, 2007
APPL NO 12/000096
ART UNIT 2191 — Interprocess Communication and Software Development
CURRENT CPC
Data processing: Software development, installation, and management
717/106
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640141 Arimilli et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Ravi K. Arimilli (Austin, Texas);  Satya P. Sharma (Austin, Texas);  Randal C. Swanberg (Round Rock, Texas)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Ravi K. Arimilli (Austin, Texas);  Satya P. Sharma (Austin, Texas);  Randal C. Swanberg (Round Rock, Texas)
ABSTRACT A wake-and-go mechanism is provided for a data processing system. When a thread is waiting for an event, rather than performing a series of get-and-compare sequences, the thread updates a wake-and-go array with a target address associated with the event. The wake-and-go mechanism may save the state of the thread in a hardware private array. The hardware private array may comprise a plurality of memory cells embodied within the processor or pervasive logic associated with the bus, for example. Alternatively, the hardware private array may be embodied within logic associated with the wake-and-go storage array.
FILED Friday, February 01, 2008
APPL NO 12/024705
ART UNIT 2196 — Interprocess Communication and Software Development
CURRENT CPC
Electrical computers and digital processing systems: Virtual machine task or process management or task management/control
718/108
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640142 Arimilli et al.
FUNDED BY
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
APPLICANT(S) Ravi K. Arimilli (Austin, Texas);  Satya P. Sharma (Austin, Texas);  Randal C. Swanberg (Round Rock, Texas)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Ravi K. Arimilli (Austin, Texas);  Satya P. Sharma (Austin, Texas);  Randal C. Swanberg (Round Rock, Texas)
ABSTRACT A wake-and-go mechanism is provided for a data processing system. When a thread first starts executing, a wake-and-go mechanism automatically allocates space for thread state in a hardware private array and space for a target address and other information, if any, in a wake-and-go array. If the hardware private array comprises a reserved portion of system memory, then the wake-and-go mechanism may request a sufficient portion of memory to store thread state for the thread. When a thread is waiting for an event, rather than performing a series of get-and-compare sequences, the thread updates a wake-and-go array with a target address associated with the event. The thread then goes to sleep until the event occurs. When a thread ends execution and is no longer in the run queue of the processor, the wake-and-go mechanism de-allocates the space for the thread state information for that thread.
FILED Monday, June 23, 2008
APPL NO 12/144011
ART UNIT 2196 — Interprocess Communication and Software Development
CURRENT CPC
Electrical computers and digital processing systems: Virtual machine task or process management or task management/control
718/108
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640147 Park et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) Yoonho Park (Hawthorne, New York);  Philippe L. Selo (Hawthorne, New York);  Chitra Venkatramani (Hawthorne, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Yoonho Park (Hawthorne, New York);  Philippe L. Selo (Hawthorne, New York);  Chitra Venkatramani (Hawthorne, New York)
ABSTRACT A method, system and computer program product of setting up a virtual connection at run time. The method includes the steps of: analyzing a topology of an application to determine at least one port pair where the port pair comprises an output port of a first operator and an input port of a second operator; configuring a first auxiliary operator to receive data from a first operator; configuring a second auxiliary operator to send data to a second operator; deploying the first operator, the second operator, the first auxiliary operator and the second auxiliary operator; receiving a function address of the second auxiliary operator; and sending the function address of the second auxiliary operator to a first destination; where at least one of the steps is carried out using a computer device so that the virtual connection is setup at run time.
FILED Thursday, November 11, 2010
APPL NO 12/944246
ART UNIT 2194 — Interprocess Communication and Software Development
CURRENT CPC
Electrical computers and digital processing systems: Interprogram communication or interprocess communication
719/320
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640189 Ernst et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) Richard J. Ernst (Rowlett, Texas);  James H. Swedberg (Richardson, Texas);  Matthew J. Hicks (Dallas, Texas);  Herbert T. Riggs, III (Grasonville, Maryland);  Matt A. Powers (Farmers Branch, Texas);  Jason E. Ostermann (Plano, Texas)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Richard J. Ernst (Rowlett, Texas);  James H. Swedberg (Richardson, Texas);  Matthew J. Hicks (Dallas, Texas);  Herbert T. Riggs, III (Grasonville, Maryland);  Matt A. Powers (Farmers Branch, Texas);  Jason E. Ostermann (Plano, Texas)
ABSTRACT In certain embodiments, a method includes receiving from a validation system a request to apply a first policy service to a message. The validation system determines whether the message may be transmitted to a second network by validating a plurality of tokens associated with the message. The method includes receiving at least one result from a policy service engine of applying the first policy service to the message and determining at least one predefined assertion based on the received at least one result. The message includes generating a first token by encrypting the at least one predefined assertion using a first parameter associated with the first service node and not the second service node. The method includes sending the message and the first token to the validation system.
FILED Monday, March 07, 2011
APPL NO 13/042367
ART UNIT 2433 — Cryptography and Security
CURRENT CPC
Information security
726/1
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Energy (DOE) 

US 08635850 Light et al.
FUNDED BY
Department of Energy (DOE)
Los Alamos National Security, LLC (LANS)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
APPLICANT(S) Max E. Light (Los Alamos, New Mexico);  Patrick L. Colestock (Santa Fe, New Mexico)
ASSIGNEE(S) U.S. Department of Energy (Washington, District of Columbia)
INVENTOR(S) Max E. Light (Los Alamos, New Mexico);  Patrick L. Colestock (Santa Fe, New Mexico)
ABSTRACT An electron cyclotron resonance (ECR) thruster is disclosed having a plasma chamber which is electrically biased with a positive voltage. The chamber bias serves to efficiently accelerate and expel the positive ions from the chamber. Electrons follow the exiting ions, serving to provide an electrically neutral exhaust plume. In a further embodiment, a downstream shaping magnetic field serves to further accelerate and/or shape the exhaust plume.
FILED Friday, August 29, 2008
APPL NO 12/201071
ART UNIT 3741 — Thermal & Combustion Technology, Motive & Fluid Power Systems
CURRENT CPC
Power plants
060/202
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636085 Rinzler et al.
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) Charles C. Rinzler (Denver, Colorado);  Mark S. Zediker (Weldon Spring, Missouri);  Brian O. Faircloth (Evergreen, Colorado);  Joel F. Moxley (Denver, Colorado)
ASSIGNEE(S) Foro Energy, Inc. (Littleton, Colorado)
INVENTOR(S) Charles C. Rinzler (Denver, Colorado);  Mark S. Zediker (Weldon Spring, Missouri);  Brian O. Faircloth (Evergreen, Colorado);  Joel F. Moxley (Denver, Colorado)
ABSTRACT The removal of material from the path of a high power laser beam during down hole laser operations including drilling of a borehole and removal of displaced laser effected borehole material from the borehole during laser operations. In particular, paths, dynamics and parameters of fluid flows for use in conjunction with a laser bottom hole assembly.
FILED Wednesday, August 19, 2009
APPL NO 12/543968
ART UNIT 3676 — Wells, Earth Boring/Moving/Working, Excavating, Mining, Harvesters, Bridges, Roads, Petroleum, Closures, Connections, and Hardware
CURRENT CPC
Boring or penetrating the earth
175/16
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636817 Scotto et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Mark Vincent Scotto (Uniontown, Ohio);  Daniel P. Birmingham (Canton, Ohio);  Crispin L. DeBellis (North Canton, Ohio);  Mark Anthony Perna (Alliance, Ohio);  Gregory C. Rush (Canton, Ohio)
ASSIGNEE(S) Rolls-Royce Fuel Cell Systems (US) Inc. (North Canton, Ohio)
INVENTOR(S) Mark Vincent Scotto (Uniontown, Ohio);  Daniel P. Birmingham (Canton, Ohio);  Crispin L. DeBellis (North Canton, Ohio);  Mark Anthony Perna (Alliance, Ohio);  Gregory C. Rush (Canton, Ohio)
ABSTRACT The present invention provides a gas generator that may be used for startup and shutdown of a fuel cell. In one non-limiting embodiment, the gas generator may include a nitrogen generator structured to receive air, extract oxygen (O2) from the air and discharge the balance in the form of a nitrogen-rich gas; a merging chamber structured to receive a hydrocarbon fuel and the nitrogen-rich gas and to discharge a feed mixture containing both the hydrocarbon fuel and the nitrogen-rich gas; and a catalytic reactor structured to receive the feed mixture and to catalytically convert the feed mixture into a reducing gas.
FILED Friday, September 04, 2009
APPL NO 12/554460
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Gas: Heating and illuminating
048/127.900
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636892 Koehl et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Argonne National Laboratory (ANL)
Federally Funded Research and Development Center (FFRDC)
Operated by UChicago Argonne, LLC (UCHICAGO) at Argonne, IL
APPLICANT(S) Eugene R. Koehl (Joliet, Illinois);  Laurel A. Barnes (Chicago, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  Mark A. Williamson (Naperville, Illinois);  James L. Willit (Batavia, Illinois)
ASSIGNEE(S) GE-Hitachi Nuclear Energy Americas LLC (Wilmington, North Carolina)
INVENTOR(S) Eugene R. Koehl (Joliet, Illinois);  Laurel A. Barnes (Chicago, Illinois);  Stanley G. Wiedmeyer (Glen Ellyn, Illinois);  Mark A. Williamson (Naperville, Illinois);  James L. Willit (Batavia, Illinois)
ABSTRACT Power distribution systems are useable in electrolytic reduction systems and include several cathode and anode assembly electrical contacts that permit flexible modular assembly numbers and placement in standardized connection configurations. Electrical contacts may be arranged at any position where assembly contact is desired. Electrical power may be provided via power cables attached to seating assemblies of the electrical contacts. Cathode and anode assembly electrical contacts may provide electrical power at any desired levels. Pairs of anode and cathode assembly electrical contacts may provide equal and opposite electrical power; different cathode assembly electrical contacts may provide different levels of electrical power to a same or different modular cathode assembly. Electrical systems may be used with an electrolyte container into which the modular cathode and anode assemblies extend and are supported above, with the modular cathode and anode assemblies mechanically and electrically connecting to the respective contacts in power distribution systems.
FILED Thursday, December 23, 2010
APPL NO 12/977839
ART UNIT 1754 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Electrolysis: Processes, compositions used therein, and methods of preparing the compositions
25/560
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08636966 Soderquist et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Battelle Memorial Institute (Richland, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) Chuck Z. Soderquist (Richland, Washington);  Amanda M. Johnsen (Richland, Washington);  Bruce K. McNamara (Richland, Washington);  Brady D. Hanson (Richland, Washington);  Steven C. Smith (Richland, Washington);  Shane M. Peper (Richland, Washington)
ABSTRACT Compositions are provided that include nuclear fuel. Methods for treating nuclear fuel are provided which can include exposing the fuel to a carbonate-peroxide solution. Methods can also include exposing the fuel to an ammonium solution. Methods for acquiring molybdenum from a uranium comprising material are provided.
FILED Monday, August 12, 2013
APPL NO 13/964914
ART UNIT 1761 — Organic Chemistry, Polymers, Compositions
CURRENT CPC
Chemistry of inorganic compounds
423/54
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637193 Steinbach et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Andrew J. L. Steinbach (Minneapolis, Minnesota);  George D. Vernstrom (Cottage Grove, Minnesota);  Mark K. Debe (Stillwater, Minnesota);  Radoslav Atanasoski (Edina, Minnesota)
ASSIGNEE(S) 3M Innovative Properties Company (St. Paul, Minnesota)
INVENTOR(S) Andrew J. L. Steinbach (Minneapolis, Minnesota);  George D. Vernstrom (Cottage Grove, Minnesota);  Mark K. Debe (Stillwater, Minnesota);  Radoslav Atanasoski (Edina, Minnesota)
ABSTRACT In some embodiments, the present disclosure provides a fuel cell catalyst having a catalyst surface bearing a non-occluding layer of iridium. In some embodiments, the present disclosure provides a fuel cell catalyst comprising a catalyst surface bearing a sub-monolayer of iridium. In some embodiments, the present disclosure provides a fuel cell catalyst comprising a catalyst surface bearing a layer of iridium having a planar equivalent thickness of between 1 and 100 Angstroms. In some embodiments, the fuel cell catalyst comprises nanostructured elements comprising microstructured support whiskers bearing a thin film of nanoscopic catalyst particles. The layer of iridium typically has a planar equivalent thickness of between 1 and 100 Angstroms and more typically between 5 and 60 Angstroms. The fuel cell catalyst typically comprises no electrically conductive carbon material and typically comprises at least a portion of the iridium in the zero oxidation state.
FILED Tuesday, August 25, 2009
APPL NO 12/546775
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Chemistry: Electrical current producing apparatus, product, and process
429/400
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637205 Iverson et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Eric J. Iverson (Eau Claire, Wisconsin);  Daniel M. Pierpont (North St. Paul, Minnesota);  Michael A. Yandrasits (Hastings, Minnesota);  Steven J. Hamrock (Stillwater, Minnesota);  Stephan J. Obradovich (Menomonie, Wisconsin);  Donald G. Peterson (Shoreview, Minnesota)
ASSIGNEE(S) 3M Innovative Properties Company (St. Paul, Minnesota)
INVENTOR(S) Eric J. Iverson (Eau Claire, Wisconsin);  Daniel M. Pierpont (North St. Paul, Minnesota);  Michael A. Yandrasits (Hastings, Minnesota);  Steven J. Hamrock (Stillwater, Minnesota);  Stephan J. Obradovich (Menomonie, Wisconsin);  Donald G. Peterson (Shoreview, Minnesota)
ABSTRACT A fuel cell roll good subassembly is described that includes a plurality of individual electrolyte membranes. One or more first subgaskets are attached to the individual electrolyte membranes. Each of the first subgaskets has at least one aperture and the first subgaskets are arranged so the center regions of the individual electrolyte membranes are exposed through the apertures of the first subgaskets. A second subgasket comprises a web having a plurality of apertures. The second subgasket web is attached to the one or more first subgaskets so the center regions of the individual electrolyte membranes are exposed through the apertures of the second subgasket web. The second subgasket web may have little or no adhesive on the subgasket surface facing the electrolyte membrane.
FILED Monday, December 20, 2010
APPL NO 12/972959
ART UNIT 1725 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Chemistry: Electrical current producing apparatus, product, and process
429/480
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637209 Jacobson et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Allan J. Jacobson (Houston, Texas);  Shuangyan Wang (Pearland, Texas);  Gun Tae Kim (Ulsan, South Korea)
ASSIGNEE(S)
INVENTOR(S) Allan J. Jacobson (Houston, Texas);  Shuangyan Wang (Pearland, Texas);  Gun Tae Kim (Ulsan, South Korea)
ABSTRACT Novel cathode, electrolyte and oxygen separation materials are disclosed that operate at intermediate temperatures for use in solid oxide fuel cells and ion transport membranes based on oxides with perovskite related structures and an ordered arrangement of A site cations. The materials have significantly faster oxygen kinetics than in corresponding disordered perovskites.
FILED Wednesday, August 09, 2006
APPL NO 11/990295
ART UNIT 1726 — Fuel Cells, Battery, Flammable Gas, Solar Cells, Liquid Crystal Compositions
CURRENT CPC
Chemistry: Electrical current producing apparatus, product, and process
429/532
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637293 Adney et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) William S. Adney (Golden, Colorado);  Michael E. Himmel (Littleton, Colorado);  Stephen R. Decker (Berthoud, Colorado);  Eric P. Knoshaug (Golden, Colorado);  Mark R. Nimlos (Golden, Colorado);  Michael F. Crowley (Lakewood, Colorado);  Tina Jeoh (Davis, California)
ASSIGNEE(S) Alliance for Sustainable Energy, LLC (Golden, Colorado)
INVENTOR(S) William S. Adney (Golden, Colorado);  Michael E. Himmel (Littleton, Colorado);  Stephen R. Decker (Berthoud, Colorado);  Eric P. Knoshaug (Golden, Colorado);  Mark R. Nimlos (Golden, Colorado);  Michael F. Crowley (Lakewood, Colorado);  Tina Jeoh (Davis, California)
ABSTRACT Provided herein is an isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide, wherein the mutations reduce N-linked glycosylation of the isolated polypeptide relative to the wild type polypeptide. Also provided herein is an isolated Cel7A polypeptide comprising increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide. The increased O-linked glycosylation is a result of the addition of and/or substitution of one or more serine and/or threonine residues to the linker domain relative to the linker domain of the wild type polypeptide. In some embodiments, the isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide further comprises increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide. The mutations in the catalytic domain reduce N-linked glycosylation of the isolated polypeptide relative to the wild type polypeptide. The addition of and/or substitution of one or more serine and/or threonine residues to the linker domain relative to the linker domain of the wild type polypeptide increases O-linked glycosylation of the isolated polypeptide. Further provided are compositions comprising such polypeptides and nucleic acids encoding such polypeptides. Still further provided are methods for making such polypeptides.
FILED Monday, May 19, 2008
APPL NO 12/123352
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/201
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637294 Day et al.
FUNDED BY
Department of Energy (DOE)
Office of Energy Efficiency and Renewable Energy (EERE)
National Renewable Energy Laboratory (NREL)
Federally Funded Research and Development Center (FFRDC)
Operated by Alliance for Sustainable Energy, LLC (ASE) at Golden, CO
APPLICANT(S) Anthony Day (San Francisco, California);  Frits Goedegebuur (Vlaardingen, Netherlands);  Peter Gualfetti (San Francisco, California);  Colin Mitchinson (Half Moon Bay, California);  Paulien Neefe (Zoetermeer, Netherlands);  Mats Sandgren (Uppsala, Sweden);  Andrew Shaw (San Francisco, California);  Jerry Stahlberg (Uppsala, Sweden)
ASSIGNEE(S) Danisco US Inc. (Palo Alto, California)
INVENTOR(S) Anthony Day (San Francisco, California);  Frits Goedegebuur (Vlaardingen, Netherlands);  Peter Gualfetti (San Francisco, California);  Colin Mitchinson (Half Moon Bay, California);  Paulien Neefe (Zoetermeer, Netherlands);  Mats Sandgren (Uppsala, Sweden);  Andrew Shaw (San Francisco, California);  Jerry Stahlberg (Uppsala, Sweden)
ABSTRACT Described herein are variants of H. jecorina CBH I, a Cel7 enzyme. The present invention provides novel cellobiohydrolases that have improved thermostability and reversibility.
FILED Thursday, March 22, 2007
APPL NO 11/728219
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/209
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637306 Young et al.
FUNDED BY
Department of Energy (DOE)
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
APPLICANT(S) Travis Young (San Diego, California);  Peter G. Schultz (La Jolla, California)
ASSIGNEE(S) The Scripps Research Institute (La Jolla, California)
INVENTOR(S) Travis Young (San Diego, California);  Peter G. Schultz (La Jolla, California)
ABSTRACT Provided are methods of making carrier polypeptide that include incorporating a first unnatural amino acid into a carrier polypeptide variant, incorporating a second unnatural amino acid into a target polypeptide variant, and reacting the first and second unnatural amino acids to produce the conjugate. Conjugates produced using the provided methods are also provided. In addition, orthogonal translation systems in methylotrophic yeast and methods of using these systems to produce carrier and target polypeptide variants comprising unnatural amino acids are provided.
FILED Wednesday, December 09, 2009
APPL NO 12/653274
ART UNIT 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/325
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637433 Painter et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
National High Magnetic Field Laboratory (NHMFL)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Thomas Painter (Tallahassee, Florida);  Ting Xu (Knoxville, Tennessee);  Xiaotao Liu (Raleigh, North Carolina)
ASSIGNEE(S) Florida State University Technology Transfer Office (Tallahassee, Florida)
INVENTOR(S) Thomas Painter (Tallahassee, Florida);  Ting Xu (Knoxville, Tennessee);  Xiaotao Liu (Raleigh, North Carolina)
ABSTRACT A method for making a composite superconductor and a superconductor made using the method. Superconducting filaments are embedded in a matrix material. Oxygen-containing elements are also embedded in the matrix material, with the oxygen-containing elements preferably being dispersed evenly among the superconducting filaments. A surrounding reinforcement material contains the other elements and preferably seals the superconductor from the surrounding atmosphere.
FILED Tuesday, October 04, 2011
APPL NO 13/252749
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Superconductor technology: Apparatus, material, process
55/492
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637813 Van Berkel et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Oak Ridge National Laboratory (ORNL)
Federally Funded Research and Development Center (FFRDC)
Operated by UT-Battelle, LLC (UTB) at Oak Ridge, TN
APPLICANT(S) Gary J. Van Berkel (Clinton, Tennessee);  Vilmos Kertesz (Knoxville, Tennessee)
ASSIGNEE(S) UT-Battelle, LLC (Oak Ridge, Tennessee)
INVENTOR(S) Gary J. Van Berkel (Clinton, Tennessee);  Vilmos Kertesz (Knoxville, Tennessee)
ABSTRACT A system and method for laser desorption of an analyte from a specimen and capturing of the analyte in a suspended solvent to form a testing solution are described. The method can include providing a specimen supported by a desorption region of a specimen stage and desorbing an analyte from a target site of the specimen with a laser beam centered at a radiation wavelength (λ). The desorption region is transparent to the radiation wavelength (λ) and the sampling probe and a laser source emitting the laser beam are on opposite sides of a primary surface of the specimen stage. The system can also be arranged where the laser source and the sampling probe are on the same side of a primary surface of the specimen stage. The testing solution can then be analyzed using an analytical instrument or undergo further processing.
FILED Friday, October 01, 2010
APPL NO 12/896018
ART UNIT 2881 — Optics
CURRENT CPC
Radiant energy
250/288
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637996 Frey
FUNDED BY
Department of Energy (DOE)
Advanced Research Projects Agency - Energy (ARPA-E)
APPLICANT(S) ITN Energy Systems, Inc. (Littleton, Colorado)
ASSIGNEE(S) ITN Energy Systems, Inc. (Littleton, Colorado)
INVENTOR(S) Jonathan Frey (Denver, Colorado)
ABSTRACT This disclosure describes systems and methods for increasing the usable surface area of electrical contacts within a device, such as a thin film solid state device, through the implementation of electrically conductive interconnects. Embodiments described herein include the use of a plurality of electrically conductive interconnects that penetrate through a top contact layer, through one or more multiple layers, and into a bottom contact layer. The plurality of conductive interconnects may form horizontal and vertical cross-sectional patterns. The use of lasers to form the plurality of electrically conductive interconnects from reflowed layer material further aids in the manufacturing process of a device.
FILED Monday, December 17, 2012
APPL NO 13/717364
ART UNIT 2813 — Semiconductors/Memory
CURRENT CPC
Active solid-state devices
257/774
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638440 Ohodnicki, Jr. et al.
FUNDED BY
Department of Energy (DOE)
Office of Fossil Energy and Carbon Management (FECM)
National Energy Technology Laboratory (NETL)
APPLICANT(S) Paul R. Ohodnicki, Jr. (Alison Park, Pennsylvania);  Congjun Wang (Bethel Park, Pennsylvania);  Mark A. Andio (Pittsburgh, Pennsylvania)
ASSIGNEE(S) U.S. Department of Energy (Washington, District of Columbia)
INVENTOR(S) Paul R. Ohodnicki, Jr. (Alison Park, Pennsylvania);  Congjun Wang (Bethel Park, Pennsylvania);  Mark A. Andio (Pittsburgh, Pennsylvania)
ABSTRACT The disclosure relates to a method of detecting a change in a chemical composition by contacting a doped oxide material with a monitored stream, illuminating the doped oxide material with incident light, collecting exiting light, monitoring an optical signal based on a comparison of the incident light and the exiting light, and detecting a shift in the optical signal. The doped metal oxide has a carrier concentration of at least 1018/cm3, a bandgap of at least 2 eV, and an electronic conductivity of at least 101 S/cm, where parameters are specified at a temperature of 25° C. The optical response of the doped oxide materials results from the high carrier concentration of the doped metal oxide, and the resulting impact of changing gas atmospheres on that relatively high carrier concentration. These changes in effective carrier densities of conducting metal oxide nanoparticles are postulated to be responsible for the change in measured optical absorption associated with free carriers. Exemplary doped metal oxides include but are not limited to Al-doped ZnO, Sn-doped In2O3, Nb-doped TiO2, and F-doped SnO2.
FILED Wednesday, June 26, 2013
APPL NO 13/927223
ART UNIT 2886 — Optics
CURRENT CPC
Optics: Measuring and testing
356/437
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638900 Altman et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) David A. Altman (Pittsburgh, Pennsylvania);  David R. Forsyth (Cheswick, Pennsylvania);  Richard E. Smith (Harrison City, Pennsylvania);  Norman R. Singleton (Murrysville, Pennsylvania)
ASSIGNEE(S) Westinghouse Electric Company LLC (Cranberry Township, Pennsylvania)
INVENTOR(S) David A. Altman (Pittsburgh, Pennsylvania);  David R. Forsyth (Cheswick, Pennsylvania);  Richard E. Smith (Harrison City, Pennsylvania);  Norman R. Singleton (Murrysville, Pennsylvania)
ABSTRACT An alignment plate that is attached to a core barrel of a pressurized water reactor and fits within slots within a top plate of a lower core shroud and upper core plate to maintain lateral alignment of the reactor internals. The alignment plate is connected to the core barrel through two vertically-spaced dowel pins that extend from the outside surface of the core barrel through a reinforcement pad and into corresponding holes in the alignment plate. Additionally, threaded fasteners are inserted around the perimeter of the reinforcement pad and into the alignment plate to further secure the alignment plate to the core barrel. A fillet weld also is deposited around the perimeter of the reinforcement pad. To accommodate thermal growth between the alignment plate and the core barrel, a gap is left above, below and at both sides of one of the dowel pins in the alignment plate holes through which the dowel pins pass.
FILED Friday, September 14, 2007
APPL NO 11/855196
ART UNIT 3646 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Induced nuclear reactions: Processes, systems, and elements
376/353
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639392 Chassin
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) David P. Chassin (Pasco, Washington)
ASSIGNEE(S) Battelle Memorial Institute (Richland, Washington)
INVENTOR(S) David P. Chassin (Pasco, Washington)
ABSTRACT Disclosed herein are representative embodiments of methods, apparatus, and systems for distributing a resource (such as electricity) using a resource allocation system. In one exemplary embodiment, a plurality of requests for electricity are received from a plurality of end-use consumers. The requests indicate a requested quantity of electricity and a consumer-requested index value indicative of a maximum price a respective end-use consumer will pay for the requested quantity of electricity. A plurality of offers for supplying electricity are received from a plurality of resource suppliers. The offers indicate an offered quantity of electricity and a supplier-requested index value indicative of a minimum price for which a respective supplier will produce the offered quantity of electricity. A dispatched index value is computed at which electricity is to be supplied based at least in part on the consumer-requested index values and the supplier-requested index values.
FILED Tuesday, September 29, 2009
APPL NO 12/587008
ART UNIT 2127 — AI & Simulation/Modeling
CURRENT CPC
Data Processing Systems or Methods, Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes; Systems or Methods Specially Adapted for Administrative, Commercial, Financial, Managerial, Supervisory or Forecasting Purposes, Not Otherwise Provided for
G06Q 30/08 (20130101)
G06Q 30/0611 (20130101)
G06Q 50/06 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639449 Weiss et al.
FUNDED BY
Department of Energy (DOE)
Office of Science (DOE-SC)
Lawrence Berkeley National Laboratory (LBNL)
Federally Funded Research and Development Center (FFRDC)
Operated by University of California (UC BERKELEY) at Berkeley, CA
APPLICANT(S) Shimon Weiss (Los Angeles, California);  Marcel Bruchez (Pittsburgh, Pennsylvania);  Paul Alivisatos (Oakland, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Shimon Weiss (Los Angeles, California);  Marcel Bruchez (Pittsburgh, Pennsylvania);  Paul Alivisatos (Oakland, California)
ABSTRACT A semiconductor nanocrystal compound and probe are described. The compound is capable of linking to one or more affinity molecules. The compound comprises (1) one or more semiconductor nanocrystals capable of, in response to exposure to a first energy, providing a second energy, and (2) one or more linking agents, having a first portion linked to the one or more semiconductor nanocrystals and a second portion capable of linking to one or more affinity molecules. One or more semiconductor nanocrystal compounds are linked to one or more affinity molecules to form a semiconductor nanocrystal probe capable of bonding with one or more detectable substances in a material being analyzed, and capable of, in response to exposure to a first energy, providing a second energy. Also described are processes for respectively: making the semiconductor nanocrystal compound; making the semiconductor nanocrystal probe; and treating materials with the probe.
FILED Friday, April 29, 2011
APPL NO 13/097430
ART UNIT 1631 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Data processing: Measuring, calibrating, or testing
72/19
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640070 Asaad et al.
FUNDED BY
Department of Energy (DOE)
APPLICANT(S) Sameh W Asaad (Briarcliff Manor, New York);  Ralph E Bellofatto (Ridgefield, Connecticut);  Bernard Brezzo (Somers, New York);  Charles L Haymes (Fair Lawn, New Jersey);  Mohit Kapur (Sleepy Hollow, New York);  Benjamin D Parker (Peekskill, New York);  Thomas Roewer (Danbury, Connecticut);  Jose A Tierno (Stamford, Connecticut)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Sameh W Asaad (Briarcliff Manor, New York);  Ralph E Bellofatto (Ridgefield, Connecticut);  Bernard Brezzo (Somers, New York);  Charles L Haymes (Fair Lawn, New Jersey);  Mohit Kapur (Sleepy Hollow, New York);  Benjamin D Parker (Peekskill, New York);  Thomas Roewer (Danbury, Connecticut);  Jose A Tierno (Stamford, Connecticut)
ABSTRACT A plurality of target field programmable gate arrays are interconnected in accordance with a connection topology and map portions of a target system. A control module is coupled to the plurality of target field programmable gate arrays. A balanced clock distribution network is configured to distribute a reference clock signal, and a balanced reset distribution network is coupled to the control module and configured to distribute a reset signal to the plurality of target field programmable gate arrays. The control module and the balanced reset distribution network are cooperatively configured to initiate and control a simulation of the target system with the plurality of target field programmable gate arrays. A plurality of local clock control state machines reside in the target field programmable gate arrays. The local clock control state machines are coupled to the balanced clock distribution network and obtain the reference clock signal therefrom. The plurality of local clock control state machines are configured to generate a set of synchronized free-running and stoppable clocks to maintain cycle-accurate and cycle-reproducible execution of the simulation of the target system. A method is also provided.
FILED Monday, November 08, 2010
APPL NO 12/941834
ART UNIT 2825 — Semiconductors/Memory
CURRENT CPC
Computer-aided design and analysis of circuits and semiconductor masks
716/116
VIEW PATENT @ USPTO:  Full Text   PDF 

National Science Foundation (NSF) 

US 08636906 Stein
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Industrial Innovation and Partnerships (IIP)
APPLICANT(S) Adam L. Stein (Venice, California)
ASSIGNEE(S) Advantageous Systems, LLC (Pasadena, California)
INVENTOR(S) Adam L. Stein (Venice, California)
ABSTRACT Disclosed are magnetic nanoparticles and methods of using magnetic nanoparticles for selectively removing biologics, small molecules, analytes, ions, or other molecules of interest from liquids.
FILED Monday, April 25, 2011
APPL NO 13/093315
ART UNIT 1778 — Chemical Apparatus, Separation and Purification, Liquid and Gas Contact Apparatus
CURRENT CPC
Liquid purification or separation
210/683
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637009 Landry et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Donald W. Landry (New York, New York);  James H. Woods (Ann Arbor, Michigan);  Roger K. Sunahara (Ann Arbor, Michigan);  Diwahar L. Narasimhan (Ann Arbor, Michigan);  Joanne MacDonald (New York, New York);  Milan N. Stojanovich (Fort Lee, New Jersey);  John J. Tesmer (Ann Arbor, Michigan);  Remy L. Brim (Farmington Hills, Michigan)
ASSIGNEE(S) The Trustees of Columbia University in the City of New York (New York, New York);  The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Donald W. Landry (New York, New York);  James H. Woods (Ann Arbor, Michigan);  Roger K. Sunahara (Ann Arbor, Michigan);  Diwahar L. Narasimhan (Ann Arbor, Michigan);  Joanne MacDonald (New York, New York);  Milan N. Stojanovich (Fort Lee, New Jersey);  John J. Tesmer (Ann Arbor, Michigan);  Remy L. Brim (Farmington Hills, Michigan)
ABSTRACT Provided are compositions comprising a cocaine esterase (CocE) and a compound that thermostabilizes the CocE. Also provided are methods of thermostabilizing a cocaine esterase. Additionally provided are methods of treating a mammal undergoing a cocaine-induced condition. Methods of determining whether a compound is a thermostabilizing agent for a protein are also provided. Uses of the above-described compositions for the treatment of a cocaine-induced condition is additionally provided. Additionally provided is an isolated nucleic acid encoding a CocE polypeptide having the substitutions L169K and G173Q, and the CocE polypeptide encoded by that nucleic acid, and pharmaceutical compositions thereof. Further provided is the use of that composition for the manufacture of a medicament for the treatment of a cocaine-induced condition and for the treatment of a cocaine-induced condition.
FILED Thursday, July 10, 2008
APPL NO 12/667895
ART UNIT 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/94.600
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637137 Joseph et al.
FUNDED BY
Department of Defense (DOD)
Missile Defense Agency (MDA)
National Science Foundation (NSF)
APPLICANT(S) Paul Jayachandran Joseph (Atlanta, Georgia);  Paul A. Kohl (Atlanta, Georgia);  Sue Ann Bidstrup Allen (Atlanta, Georgia)
ASSIGNEE(S) Georgia Tech Research Corporation (Atlanta, Georgia)
INVENTOR(S) Paul Jayachandran Joseph (Atlanta, Georgia);  Paul A. Kohl (Atlanta, Georgia);  Sue Ann Bidstrup Allen (Atlanta, Georgia)
ABSTRACT Microstructures and methods of fabricating microstructures are disclosed. One exemplary microstructure, among others, includes a substrate, an overcoat layer disposed upon the substrate, an air-region within at least a portion of the overcoat layer, and a framing material layer engaging at least a portion of the air-region on the inside of the framing material layer and engaging the overcoat layer on the outside of the framing material layer.
FILED Thursday, January 25, 2007
APPL NO 11/657769
ART UNIT 1783 — Miscellaneous Articles, Stock Material
CURRENT CPC
Stock material or miscellaneous articles
428/161
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637141 Gemici et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Zekeriyya Gemici (Cambridge, Massachusetts);  Michael F. Rubner (Westford, Massachusetts);  Robert E. Cohen (Jamaica Plain, Massachusetts)
ASSIGNEE(S) Massachusetts Institute of Technology (Cambridge, Massachusetts)
INVENTOR(S) Zekeriyya Gemici (Cambridge, Massachusetts);  Michael F. Rubner (Westford, Massachusetts);  Robert E. Cohen (Jamaica Plain, Massachusetts)
ABSTRACT A superhydrophilic coating can be antireflective and antifogging. The coating can remain antireflective and antifogging for extended periods. The coating can have a graded refractive index. The coating for wafer-level optics can be for targeted capillary condensation in nanoparticle containing reflow-compatible coatings.
FILED Thursday, May 28, 2009
APPL NO 12/473803
ART UNIT 1781 — Miscellaneous Articles, Stock Material
CURRENT CPC
Stock material or miscellaneous articles
428/212
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637301 Wang et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Cancer Institute (NCI)
National Science Foundation (NSF)
APPLICANT(S) Jeff Tza-Huei Wang (Baltimore, Maryland);  Kelvin J. Liu (Baltimore, Maryland);  Christopher M. Puleo (Glenville, New York);  Tushar D. Rane (Baltimore, Maryland)
ASSIGNEE(S) The Johns Hopkins University (Baltimore, Maryland)
INVENTOR(S) Jeff Tza-Huei Wang (Baltimore, Maryland);  Kelvin J. Liu (Baltimore, Maryland);  Christopher M. Puleo (Glenville, New York);  Tushar D. Rane (Baltimore, Maryland)
ABSTRACT A microfluidic device for a confocal fluorescence detection system has an input channel defined by a body of the microfluidic device, a sample concentration section defined by the body of the microfluidic device and in fluid connection with the input channel, a mixing section defined by the body of the microfluidic device and in fluid connection with the concentration section, and a detection region that is at least partially transparent to illumination light of the confocal fluorescence detection system and at least partially transparent to fluorescent light when emitted from a sample under observation as the sample flows through the detection region.
FILED Tuesday, March 02, 2010
APPL NO 13/147742
ART UNIT 1634 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/283.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637344 Kummel et al.
FUNDED BY
Department of Defense (DOD)
Department of the Air Force (DAF)
Air Force Office of Scientific Research (AFOSR)
National Science Foundation (NSF)
APPLICANT(S) Andrew C. Kummel (San Diego, California);  Jeongwon Park (Palo Alto, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Andrew C. Kummel (San Diego, California);  Jeongwon Park (Palo Alto, California)
ABSTRACT A method for forming a thin film electrode for an organic thin film transistor of the invention provides a multi-layer mask on a substrate with an electrode area opening in a top layer of the mask that is undercut by openings in other layers of the mask. A thin film of metal is deposited in the electrode area on the substrate. Removing the multi-layer mask leaves a well-formed thin film electrode with naturally tapered edges. A preferred embodiment of the invention is a method for forming a thin film electrode for an organic thin film transistor. The method includes depositing a first layer of photoresist on a substrate. The photoresist of the first layer has a first etching rate. A second layer of photoresist is deposited on the first layer of photoresist. The photoresist of the second layer has a second etching rate that is lower than the first etching rate. The first and second layer of photoresist are patterned by exposure. Developing the first and second layers of photoresist provides an electrode area on the substrate. An electrode is deposited in the electrode area. Lift-off of the first and second layers is performed. The electrode that is deposited has a tailored, tapered edge. A preferred embodiment thin film electrode in an organic thin film transistor has a tapered edge with a contact angle of approximately +40±4.4°.
FILED Tuesday, April 21, 2009
APPL NO 12/936586
ART UNIT 2815 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/99
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637356 Somu et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
Nanoscale Science and Engineering Centers (NSF-NSEC)
APPLICANT(S) Sivasubramanian Somu (Boston, Massachusetts);  Ahmed Busnaina (Ashland, Massachusetts);  Nicol McGruer (Dover, Massachusetts);  Peter Ryan (Waltham, Massachusetts);  George G. Adams (West Newton, Massachusetts);  Xugang Xiong (Boston, Massachusetts);  Taehoon Kim (Boston, Massachusetts)
ASSIGNEE(S) Northeastern University (Boston, Massachusetts)
INVENTOR(S) Sivasubramanian Somu (Boston, Massachusetts);  Ahmed Busnaina (Ashland, Massachusetts);  Nicol McGruer (Dover, Massachusetts);  Peter Ryan (Waltham, Massachusetts);  George G. Adams (West Newton, Massachusetts);  Xugang Xiong (Boston, Massachusetts);  Taehoon Kim (Boston, Massachusetts)
ABSTRACT A non-volatile bistable nano-electromechanical switch is provided for use in memory devices and microprocessors. The switch employs carbon nanotubes as the actuation element. A method has been developed for fabricating nanoswitches having one single-walled carbon nanotube as the actuator. The actuation of two different states can be achieved using the same low voltage for each state.
FILED Wednesday, June 27, 2012
APPL NO 13/534105
ART UNIT 2812 — Semiconductors/Memory
CURRENT CPC
Semiconductor device manufacturing: Process
438/151
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637433 Painter et al.
FUNDED BY
Department of Energy (DOE)
National Nuclear Security Administration (NNSA)
Los Alamos National Laboratory (LANL)
Federally Funded Research and Development Center (FFRDC)
Operated by Triad National Security, LLC (TRIAD) at Los Alamos, NM
National High Magnetic Field Laboratory (NHMFL)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Materials Research (DMR)
APPLICANT(S) Thomas Painter (Tallahassee, Florida);  Ting Xu (Knoxville, Tennessee);  Xiaotao Liu (Raleigh, North Carolina)
ASSIGNEE(S) Florida State University Technology Transfer Office (Tallahassee, Florida)
INVENTOR(S) Thomas Painter (Tallahassee, Florida);  Ting Xu (Knoxville, Tennessee);  Xiaotao Liu (Raleigh, North Carolina)
ABSTRACT A method for making a composite superconductor and a superconductor made using the method. Superconducting filaments are embedded in a matrix material. Oxygen-containing elements are also embedded in the matrix material, with the oxygen-containing elements preferably being dispersed evenly among the superconducting filaments. A surrounding reinforcement material contains the other elements and preferably seals the superconductor from the surrounding atmosphere.
FILED Tuesday, October 04, 2011
APPL NO 13/252749
ART UNIT 1736 — Metallurgy, Metal Working, Inorganic Chemistry, Catalyst, Electrophotography, Photolithography
CURRENT CPC
Superconductor technology: Apparatus, material, process
55/492
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637696 Gellman et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Mathematical and Physical Sciences (MPS)
Division of Chemistry (CHE)
APPLICANT(S) Samuel Helmer Gellman (Madison, Wisconsin);  Yonggui Chi (Berkeley, California);  Li Guo (Madison, Wisconsin)
ASSIGNEE(S) Wisconsin Alumni Research Foundation (Madison, Wisconsin)
INVENTOR(S) Samuel Helmer Gellman (Madison, Wisconsin);  Yonggui Chi (Berkeley, California);  Li Guo (Madison, Wisconsin)
ABSTRACT The invention provides novel compounds and methods to carry out organocatalytic Michael additions of aldehydes to nitroethylene catalyzed by a proline derivative to provide α-substituted-γ-nitroaldehydes. The reaction can be rendered enantioselective when a chiral pyrrolidine catalyst is used, allowing for Michael adducts in nearly optically pure form (e.g., 96-99% e.e.). The Michael adducts can bear a single substituent or dual substituents adjacent to the carbonyl. The Michael adducts can be efficiently converted to protected γ2-amino acids, which are essential for systematic conformational studies of γ-peptide foldamers.
FILED Monday, September 17, 2012
APPL NO 13/621553
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Acyclic or Carbocyclic Compounds
C07C 227/02 (20130101)
C07C 269/00 (20130101)
C07C 271/22 (20130101) Original (OR) Class
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638106 Gianchandani et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
Directorate for Engineering (ENG)
Division of Engineering Education and Centers (EEC)
APPLICANT(S) Yogesh B. Gianchandani (Ann Arbor, Michigan);  Scott Andrew Wright (Ann Arbor, Michigan)
ASSIGNEE(S) The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Yogesh B. Gianchandani (Ann Arbor, Michigan);  Scott Andrew Wright (Ann Arbor, Michigan)
ABSTRACT A microdischarge-based pressure sensor that includes an anode, two cathodes, a drive circuit connected to the electrodes, and a measurement circuit that permits sensing of transient current pulses flowing through at least one of the electrodes. One of the cathodes is interposed between the anode and other cathode, and it includes a central opening which permits a microdischarge to occur between the anode and each cathode in response to applied voltage pulses from the drive circuit. Changes in relative current between the two cathodes are indicative of changes in ambient pressure in the microdischarge chamber. In other embodiments, a sealed chamber can be used with one of the electrodes acting as a diaphragm which deflects based on external pressure and changes its inter-electrode spacing, thereby altering the relative cathode currents.
FILED Friday, May 28, 2010
APPL NO 12/789601
ART UNIT 2858 — Printing/Measuring and Testing
CURRENT CPC
Electricity: Measuring and testing
324/460
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638269 Cortes-Medellin
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) German Cortes-Medellin (Ithaca, New York)
ASSIGNEE(S) Cornell University (Ithaca, New York)
INVENTOR(S) German Cortes-Medellin (Ithaca, New York)
ABSTRACT A non-planar, ultra-wide band, quasi-self-complementary feed antenna is disclosed. The antenna provides an invariant phase center location over its entire frequency band, is compact and includes a low profile, and includes input matching better than is currently available over a decade of frequency bandwidth. The very compact feed couples dual polarization electromagnetic energy to a transmitter from free space or air with minimum losses and mismatches over a very wide frequency band.
FILED Thursday, June 05, 2008
APPL NO 12/663226
ART UNIT 2845 — Electrical Circuits and Systems
CURRENT CPC
Communications: Radio wave antennas
343/792.500
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638872 Fazel et al.
FUNDED BY
National Science Foundation (NSF)
APPLICANT(S) Fatemeh Fazel (Boston, Massachusetts);  Alfred Grau Besoli (Irvine, California);  Hamid Jafakhani (Irvine, California);  Franco De Flaviis (Irvine, California)
ASSIGNEE(S) The Regents of the University of California (Oakland, California)
INVENTOR(S) Fatemeh Fazel (Boston, Massachusetts);  Alfred Grau Besoli (Irvine, California);  Hamid Jafakhani (Irvine, California);  Franco De Flaviis (Irvine, California)
ABSTRACT Space-Time-State Block Coded MIMO communication system using reconfigurable antennas. One or more antennas are operates in accordance with a Space-Time-State Block Code (STS-BC) to effectuate channel coding of a signal being transmitted wirelessly between communication devices. In accordance with such an STS-BC, one or more antennas (being reconfigurable in nature) of a communication device are reconfigured in different radiation states. From some perspectives, this may be viewed as performing three-dimensional channel coding, in that, in addition to achieving at least time diversity of signals being transmitted (and also potentially including spatial diversity), state diversity may be achieved by adapting one or more characteristics of one or more antennas within the communication device. Such an STS-BC may operate in an open loop configuration without requiring any feedback from another communication device to which signals are transmitted. If desired, feedback may be employed for adaptively modifying an STS-BC (or selecting another STS-BC).
FILED Friday, March 26, 2010
APPL NO 12/748366
ART UNIT 2631 — Digital Communications
CURRENT CPC
Pulse or digital communications
375/267
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639064 Yu et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Electrical and Communications Systems (ECS)
APPLICANT(S) Zongfu Yu (Stanford, California);  Shanhui Fan (Palo Alto, California)
ASSIGNEE(S) The Board of Trustees of the Leland Stanford Junior University (Palo Alto, California)
INVENTOR(S) Zongfu Yu (Stanford, California);  Shanhui Fan (Palo Alto, California)
ABSTRACT The refractive index of the at least one photonic structure having two separate photonic bands is modulated, so that light supplied to the at least one photonic structure and initially in one of the two photonic bands of the traveling along a forward direction in the at least one photonic structure is converted to light in a second one of the photonic bands, and light in the one photonic band traveling along a backward direction opposite to the forward direction in the at least one photonic structure is not converted and remains in the one photonic band, achieving non-reciprocity.
FILED Wednesday, July 01, 2009
APPL NO 12/496474
ART UNIT 2874 — Optics
CURRENT CPC
Optical waveguides
385/2
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639311 Giszter
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Directorate for Computer and Information Science and Engineering (CISE)
Division of Information and Intelligent Systems (IIS)
APPLICANT(S) Simon F. Giszter (Havertown, Pennsylvania)
ASSIGNEE(S) Philadelphia Health and Education Corporation (Philadelphia, Pennsylvania)
INVENTOR(S) Simon F. Giszter (Havertown, Pennsylvania)
ABSTRACT A single sensing probe comprising multiple, spatially separate, sensing sites is utilized to sense neural activity. The sensing probe includes multiple conductors each with multiple sensing sites in a fixed geometric arrangement. The sensing probe is configured to comprise multiple combined sensing sites in polytrode configuration. By appropriately combining the wire groupings at each combined sensing site, activity sensed from a single wire with multiple sensing sites, can be coupled with other wires to unmix signals from the spatially separate sites and leverage the power of combinatorics to maximize total recording bandwidth and single neuron/unit yield per wire and per probe.
FILED Tuesday, December 14, 2010
APPL NO 12/967878
ART UNIT 3739 — Optics
CURRENT CPC
Surgery
6/377
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08639437 Caminiti et al.
FUNDED BY
National Science Foundation (NSF)
Directorate for Engineering (ENG)
Division of Civil, Mechanical and Manufacturing Innovation (CMMI)
APPLICANT(S) Lorenzo Caminiti (Ann Arbor, Michigan);  Evan Quisenberry (Berkley, Michigan);  Christopher Peplin (Pittsburgh, Pennsylvania);  Domitilla Del Vecchio (Ann Arbor, Michigan);  Rajeev Verma (Ann Arbor, Michigan)
ASSIGNEE(S) Toyota Motor Engineering and Manufacturing North America, Inc. (Erlanger, Kentucky);  The Regents of the University of Michigan (Ann Arbor, Michigan)
INVENTOR(S) Lorenzo Caminiti (Ann Arbor, Michigan);  Evan Quisenberry (Berkley, Michigan);  Christopher Peplin (Pittsburgh, Pennsylvania);  Domitilla Del Vecchio (Ann Arbor, Michigan);  Rajeev Verma (Ann Arbor, Michigan)
ABSTRACT The present invention discloses a back-propagating intersection collision avoidance (ICA) system for preventing two or more vehicles from colliding at an intersection. The ICA system can calculate predicted positions of the two or more vehicles in the near future, and both the current and future positions can be broadcast to surrounding vehicles using vehicle-to-vehicle communication. For each vehicle, a set of states, for example position, speed, acceleration, and the like, where a collision is imminent can be identified using state information for a local vehicle, a remote vehicle, and a known collision zone for the intersection. If the current states of the vehicles are determined to be in danger of entering the collision zone, the ICA system can control the vehicles to perform evasive driving maneuvers and/or alert the drivers.
FILED Wednesday, June 09, 2010
APPL NO 12/796978
ART UNIT 3661 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems
CURRENT CPC
Data processing: Vehicles, navigation, and relative location
71/301
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Agriculture (USDA) 

US 08637002 Dorner et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Joe W. Dorner (Albany, Georgia);  Bruce W. Horn (Albany, Georgia)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Joe W. Dorner (Albany, Georgia);  Bruce W. Horn (Albany, Georgia)
ABSTRACT Non-toxigenic strains of Aspergillus are useful biocontrol agents for preventing toxin contamination in agricultural commodities, especially those for human consumption such as peanuts and corn, for example.
FILED Wednesday, January 19, 2011
APPL NO 13/009430
ART UNIT 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/93.500
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637049 Pridgeon et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Yuping Wei Pridgeon (Auburn, Alabama);  Phillip H. Klesius (Auburn, Alabama)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Yuping Wei Pridgeon (Auburn, Alabama);  Phillip H. Klesius (Auburn, Alabama)
ABSTRACT Safe and effective live vaccines against bacteria infecting aquatic animals were created through the induction of novobiocin-resistance in liquid culture and novobiocin- and rifampicin-resistance in liquid culture.
FILED Wednesday, April 06, 2011
APPL NO 13/081134
ART UNIT 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/244.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637237 Henrich et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Department of Agriculture (USDA)
APPLICANT(S) Vincent C. Henrich (Greensboro, North Carolina);  Cary Alan Weinberger (Carrboro, North Carolina)
ASSIGNEE(S) The University of North Carolina at Greensboro (Greensboro, North Carolina)
INVENTOR(S) Vincent C. Henrich (Greensboro, North Carolina);  Cary Alan Weinberger (Carrboro, North Carolina)
ABSTRACT Ecdysteroid action in Drosophila melanogaster and other insects is mediated by the dimerization of two nuclear receptors, the ecdysone receptor (EcR) and Ultraspiracle (USP), which regulate the transcription of target genes. Disclosed are nucleic acid constructs to identify insecticides having the ability to modify insect development and growth in a developmental stage-specific and/or species-specific manner.
FILED Thursday, October 05, 2006
APPL NO 11/543682
ART UNIT 1636 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/6.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637304 Burke
FUNDED BY
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Dennis A. Burke (Olympia, Washington)
ASSIGNEE(S)
INVENTOR(S) Dennis A. Burke (Olympia, Washington)
ABSTRACT An economical method for recovering nitrogen from liquid waste using autotrophic organisms and minimal energy inputs and without chemical additives. Solids are separated from anaerobically digested liquid waste. The resulting translucent liquid is introduced to a culture of autotrophic microorganisms in the presence of natural or artificial light, thereby accumulating biomass and producing a liquid effluent with elevated pH. The elevated-pH, liquid effluent is heated and stripped of ammonia, thereby producing a water vapor and stripped ammonia gas stream. The water vapor ammonia gas stream is condensed to form a liquid/ammonia condensate. The autotrophic microorganisms are advantageously cultivated in a photobioreactor comprising a plurality of axially spaced-apart, growth plates mounted for rotation to a shaft. The pH of the culture is adjustable within a preferred range of 8.0 to 10.5 by adjusting the light intensity and rotational speed.
FILED Thursday, December 01, 2011
APPL NO 13/373860
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/290.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637325 Basile et al.
FUNDED BY
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Center for Research Resources (NCRR)
Department of Agriculture (USDA)
APPLICANT(S) Franco Basile (Fort Collins, Colorado);  Shaofeng Zhang (Exton, Pennsylvania)
ASSIGNEE(S) University of Wyoming (Laramie, Wyoming)
INVENTOR(S) Franco Basile (Fort Collins, Colorado);  Shaofeng Zhang (Exton, Pennsylvania)
ABSTRACT A method and apparatus for conducting the rapid pyrolysis of peptides, proteins, polymers, and biological materials. The method can be carried out at atmospheric pressures and takes only about 5 to 30 seconds. The samples are cleaved at the C-terminus of aspartic acid. The apparatus employs a probe on which the sample is heated and digested components analyzed.
FILED Monday, February 16, 2009
APPL NO 12/371893
ART UNIT 2881 — Optics
CURRENT CPC
Chemistry: Analytical and immunological testing
436/501
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637653 Hammond et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) John Hammond (Laurel, Maryland);  Hyoun Sub Lim (Ellicott City, Maryland);  Leslie L. Domier (Urbana, Illinois)
ASSIGNEE(S) The United States of America, as represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) John Hammond (Laurel, Maryland);  Hyoun Sub Lim (Ellicott City, Maryland);  Leslie L. Domier (Urbana, Illinois)
ABSTRACT We have developed a versatile plant viral vector system based on Alternanthera mosaic virus (AltMV), suitable for infection by agroinfiltration or in vivo T7 transcripts from the same clone; agroinfection is enhanced by coinfiltration of a T7 RNA polymerase construct. Variants adapted for efficient protein expression, or for virus-induced gene silencing (VIGS), are based on a specific amino acid substitution (L88P) in the triple gene block 1 (TGB1) protein affecting RNA silencing suppression. A bipartite delivery system developed for AltMV delivers replicase (RdRp) functions separately from movement and encapsidation (TGB and coat protein, CP) functions by agroinfiltration, resulting in precise recombination of RdRp and TGB-CP constructs in planta. The bipartite delivery system has potential for high throughput protein expression or VIGS with the appropriate TGB1 variant, for hosts including Nicotiana benthamiana and Arabidopsis thaliana. Equivalent TGB1 substitutions in other potexviruses also reduced RNA silencing suppression, demonstrated with Potato virus X.
FILED Tuesday, December 22, 2009
APPL NO 12/645027
ART UNIT 1638 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Organic compounds
536/23.720
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637689 Bredsguard et al.
FUNDED BY
Department of Agriculture (USDA)
Agricultural Research Service (ARS)
APPLICANT(S) Jakob Bredsguard (Irvine, California);  Jeremy Forest (Tustin, California);  Travis Thompson (Anaheim, California)
ASSIGNEE(S) Biosynthetic Technologies, LLC (Irvine, California)
INVENTOR(S) Jakob Bredsguard (Irvine, California);  Jeremy Forest (Tustin, California);  Travis Thompson (Anaheim, California)
ABSTRACT Provided herein are processes for preparing estolides and estolide base oils from fatty acid reactants utilizing catalysts. Further provided herein are processes for preparing carboxylic esters from at least one carboxylic acid reactant and at least one olefin.
FILED Wednesday, August 31, 2011
APPL NO 13/199551
ART UNIT 1621 — Organic Chemistry
CURRENT CPC
Organic compounds
554/122
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637738 Kidwell et al.
FUNDED BY
Department of Agriculture (USDA)
APPLICANT(S) Kimberlee Kae Kidwell (Pullman, Washington);  Camille Marie Steber (Pullman, Washington);  Victor Louis Demacon (Pullman, Washington);  Gary Bruce Shelton (Albion, Washington);  Adrienne Bryan Burke (Pullman, Washington)
ASSIGNEE(S) Washington State University (Pullman, Washington);  The United States of America as represented by the Secretary of Agriculture (Washington, District of Columbia)
INVENTOR(S) Kimberlee Kae Kidwell (Pullman, Washington);  Camille Marie Steber (Pullman, Washington);  Victor Louis Demacon (Pullman, Washington);  Gary Bruce Shelton (Albion, Washington);  Adrienne Bryan Burke (Pullman, Washington)
ABSTRACT The present invention provides methods for producing glyphosate-tolerant wheat genotypes by mutagenesis, glyphosate wheat plants produced by such methods, and related compositions and methods.
FILED Thursday, August 07, 2008
APPL NO 12/672504
ART UNIT 1638 — Organic Chemistry
CURRENT CPC
Multicellular living organisms and unmodified parts thereof and related processes
8/300
VIEW PATENT @ USPTO:  Full Text   PDF 

Small Business Administration (SBA) 

US 08635916 Loverich et al.
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) Jacob Loverich (State Colleg, Pennsylvania);  Stephen J. Wenner (Port Matilda, Pennsylvania);  Jeremy E. Frank (Pine Grove Mills, Pennsylvania)
ASSIGNEE(S)
INVENTOR(S) Jacob Loverich (State Colleg, Pennsylvania);  Stephen J. Wenner (Port Matilda, Pennsylvania);  Jeremy E. Frank (Pine Grove Mills, Pennsylvania)
ABSTRACT An internal structural monitoring system for a structure that includes a sensor mounted within the structure to measure at least one of strain experienced by the structure and vibration experience by the structure. It includes a first system support mounted and second system support mounted in the structure, where the first system and the second system support are mounted in the structure such that the sensor is between the first system support and the second system support to hold the sensor in position so that the sensor senses at least one of strain and vibration. It includes a wireless communication unit mounted within the structure, the wireless communication unit connected to the sensor to receive data from the sensor and transmit the data to a receiver outside the structure. It includes a power supply mounted within the structure to supply necessary electrical power to the sensor and the communication unit.
FILED Wednesday, July 06, 2011
APPL NO 13/176959
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Measuring and testing
073/768
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637304 Burke
FUNDED BY
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
Department of Agriculture (USDA)
National Institute of Food and Agriculture (NIFA)
APPLICANT(S) Dennis A. Burke (Olympia, Washington)
ASSIGNEE(S)
INVENTOR(S) Dennis A. Burke (Olympia, Washington)
ABSTRACT An economical method for recovering nitrogen from liquid waste using autotrophic organisms and minimal energy inputs and without chemical additives. Solids are separated from anaerobically digested liquid waste. The resulting translucent liquid is introduced to a culture of autotrophic microorganisms in the presence of natural or artificial light, thereby accumulating biomass and producing a liquid effluent with elevated pH. The elevated-pH, liquid effluent is heated and stripped of ammonia, thereby producing a water vapor and stripped ammonia gas stream. The water vapor ammonia gas stream is condensed to form a liquid/ammonia condensate. The autotrophic microorganisms are advantageously cultivated in a photobioreactor comprising a plurality of axially spaced-apart, growth plates mounted for rotation to a shaft. The pH of the culture is adjustable within a preferred range of 8.0 to 10.5 by adjusting the light intensity and rotational speed.
FILED Thursday, December 01, 2011
APPL NO 13/373860
ART UNIT 1657 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes
CURRENT CPC
Chemistry: Molecular biology and microbiology
435/290.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638963 Parkins
FUNDED BY
Department of Defense (DOD)
Department of the Navy (DON)
Small Business Administration (SBA)
Small Business Innovation Research (SBIR)
APPLICANT(S) John W. Parkins (Ithaca, New York)
ASSIGNEE(S) Red Tail Hawk Corporation (Ithaca, New York)
INVENTOR(S) John W. Parkins (Ithaca, New York)
ABSTRACT A hearing protection system with talk-through having a pair of rigid earcups enclosing a microphone, amplifier and speaker. A concha simulator, having a volume simulating that of the concha of a human ear, is acoustically coupled to the microphone, and also to the outside through an opening in the earcup. By coupling the microphone to the concha simulator, instead of directly to the outside, the acoustic response of the talk-through more accurately represents the hearing of a user.
FILED Friday, May 28, 2010
APPL NO 12/789942
ART UNIT 2832 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review
CURRENT CPC
Electrical audio signal processing systems and devices
381/322
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Commerce (DOC) 

US 08637082 Tulsky et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
APPLICANT(S) Eric Tulsky (Berkeley, California);  Joseph Bartel (Eugene, Oregon);  Joseph Treadway (Eugene, Oregon)
ASSIGNEE(S) Life Technologies Corporation (Carlsbad, California)
INVENTOR(S) Eric Tulsky (Berkeley, California);  Joseph Bartel (Eugene, Oregon);  Joseph Treadway (Eugene, Oregon)
ABSTRACT Nanocrystals having a ZnTe core and methods for making and using them to construct core-shell nanocrystals are described. These core-shell nanocrystals are highly stable and provide quantum yields and stability suitable for applications such as flow cytometry, cellular imaging, and protein blotting, medical imaging, and other applications where cadmium toxicity is an issue.
FILED Friday, October 02, 2009
APPL NO 13/119170
ART UNIT 1618 — Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/489
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08638998 Steines et al.
FUNDED BY
Department of Commerce (DOC)
National Institute of Standards and Technology (NIST)
Advanced Technology Program (NIST-ATP)
APPLICANT(S) Daniel Steines (Lexington, Massachusetts);  Bijan Timsari (San Diego, California);  Konstantinos Tsougarakis (San Francisco, California);  Philipp Lang (Lexington, Massachusetts)
ASSIGNEE(S) ConforMIS, Inc. (Bedford, Massachusetts)
INVENTOR(S) Daniel Steines (Lexington, Massachusetts);  Bijan Timsari (San Diego, California);  Konstantinos Tsougarakis (San Francisco, California);  Philipp Lang (Lexington, Massachusetts)
ABSTRACT In accordance with the present invention there is provided methods for generating an isotropic or near-isotropic three-dimensional images from two-dimensional images. In accordance with the present invention the method includes, obtaining a first image of a body part in a first plane, wherein the first image generates a first image data volume; obtaining a second image of the body part in a second plane, wherein the second image generates a second image data volume; and combining the first and second image data volumes to form a resultant image data volume, wherein the resultant image data volume is isotropic or near-isotropic.
FILED Monday, January 09, 2012
APPL NO 13/345843
ART UNIT 2666 — Image Analysis; Applications; Pattern Recognition; Color and compression; Enhancement and Transformation
CURRENT CPC
Image analysis
382/128
VIEW PATENT @ USPTO:  Full Text   PDF 

National Security Agency (NSA) 

US 08640147 Park et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) Yoonho Park (Hawthorne, New York);  Philippe L. Selo (Hawthorne, New York);  Chitra Venkatramani (Hawthorne, New York)
ASSIGNEE(S) International Business Machines Corporation (Armonk, New York)
INVENTOR(S) Yoonho Park (Hawthorne, New York);  Philippe L. Selo (Hawthorne, New York);  Chitra Venkatramani (Hawthorne, New York)
ABSTRACT A method, system and computer program product of setting up a virtual connection at run time. The method includes the steps of: analyzing a topology of an application to determine at least one port pair where the port pair comprises an output port of a first operator and an input port of a second operator; configuring a first auxiliary operator to receive data from a first operator; configuring a second auxiliary operator to send data to a second operator; deploying the first operator, the second operator, the first auxiliary operator and the second auxiliary operator; receiving a function address of the second auxiliary operator; and sending the function address of the second auxiliary operator to a first destination; where at least one of the steps is carried out using a computer device so that the virtual connection is setup at run time.
FILED Thursday, November 11, 2010
APPL NO 12/944246
ART UNIT 2194 — Interprocess Communication and Software Development
CURRENT CPC
Electrical computers and digital processing systems: Interprogram communication or interprocess communication
719/320
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08640189 Ernst et al.
FUNDED BY
Department of Defense (DOD)
National Security Agency (NSA)
APPLICANT(S) Richard J. Ernst (Rowlett, Texas);  James H. Swedberg (Richardson, Texas);  Matthew J. Hicks (Dallas, Texas);  Herbert T. Riggs, III (Grasonville, Maryland);  Matt A. Powers (Farmers Branch, Texas);  Jason E. Ostermann (Plano, Texas)
ASSIGNEE(S) Raytheon Company (Waltham, Massachusetts)
INVENTOR(S) Richard J. Ernst (Rowlett, Texas);  James H. Swedberg (Richardson, Texas);  Matthew J. Hicks (Dallas, Texas);  Herbert T. Riggs, III (Grasonville, Maryland);  Matt A. Powers (Farmers Branch, Texas);  Jason E. Ostermann (Plano, Texas)
ABSTRACT In certain embodiments, a method includes receiving from a validation system a request to apply a first policy service to a message. The validation system determines whether the message may be transmitted to a second network by validating a plurality of tokens associated with the message. The method includes receiving at least one result from a policy service engine of applying the first policy service to the message and determining at least one predefined assertion based on the received at least one result. The message includes generating a first token by encrypting the at least one predefined assertion using a first parameter associated with the first service node and not the second service node. The method includes sending the message and the first token to the validation system.
FILED Monday, March 07, 2011
APPL NO 13/042367
ART UNIT 2433 — Cryptography and Security
CURRENT CPC
Information security
726/1
VIEW PATENT @ USPTO:  Full Text   PDF 

Department of Justice (DOJ) 

US 08637654 Ballantyne et al.
FUNDED BY
Department of Justice (DOJ)
Federal Bureau of Investigation (FBI)
APPLICANT(S) John Ballantyne (Orlando, Florida);  Jane Juusola (Glen Allen, Virginia)
ASSIGNEE(S) University of Central Florida Research Foundation, Inc. (Orlando, Florida)
INVENTOR(S) John Ballantyne (Orlando, Florida);  Jane Juusola (Glen Allen, Virginia)
ABSTRACT This invention relates to a ribonucleic acid (RNA) based assay system for body fluid identification, and in particular to a novel, multiplex, parallel assay system based on messenger RNA expressed in human tissue, and to a method for using the same.
FILED Tuesday, September 01, 2009
APPL NO 12/584140
ART UNIT 1637 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry
CURRENT CPC
Organic compounds
536/24.300
VIEW PATENT @ USPTO:  Full Text   PDF 

National Aeronautics and Space Administration (NASA) 

US 08636407 Woodard
FUNDED BY
National Aeronautics and Space Administration (NASA)
APPLICANT(S) Marie Woodard (Hampton, Virginia)
ASSIGNEE(S) United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia)
INVENTOR(S) Marie Woodard (Hampton, Virginia)
ABSTRACT A wireless temperature sensor includes an electrical conductor and a dielectric material on the conductor. The conductor is electrically unconnected and is shaped for storage of an electric field and a magnetic field. In the presence of a time-varying magnetic field, the conductor resonates to generate harmonic electric and magnetic field responses, each of which has a frequency associated therewith. The material is selected such that it experiences changes in either dielectric or magnetic permeability attributes in the presence of a temperature change. Shifts from the sensor's baseline frequency response indicate that the material has experienced a temperature change.
FILED Thursday, February 17, 2011
APPL NO 13/029426
ART UNIT 2856 — Printing/Measuring and Testing
CURRENT CPC
Thermal measuring and testing
374/120
VIEW PATENT @ USPTO:  Full Text   PDF 

National Geospatial Intelligence Agency (NGA) 

US 08639502 Boucheron et al.
FUNDED BY
National Geospatial Intelligence Agency (NGA)
APPLICANT(S) Laura E. Boucheron (Las Cruces, New Mexico);  Phillip L. De Leon (Las Cruces, New Mexico)
ASSIGNEE(S) Arrowhead Center, Inc. (Las Cruces, New Mexico)
INVENTOR(S) Laura E. Boucheron (Las Cruces, New Mexico);  Phillip L. De Leon (Las Cruces, New Mexico)
ABSTRACT A speech enhancement method (and concomitant computer-readable medium comprising computer software encoded thereon) comprising receiving samples of a user's speech, determining mel-frequency cepstral coefficients of the samples, constructing a Gaussian mixture model of the coefficients, receiving speech from a noisy environment, determining mel-frequency cepstral coefficients of the noisy speech, estimating mel-frequency cepstral coefficients of clean speech from the mel-frequency cepstral coefficients of the noisy speech and from the Gaussian mixture model, and outputting a time-domain waveform of enhanced speech computed from the estimated mel-frequency cepstral coefficients.
FILED Tuesday, February 16, 2010
APPL NO 12/706482
ART UNIT 2657 — Linguistics, Speech Processing and Audio Compression
CURRENT CPC
Data processing: Speech signal processing, linguistics, language translation, and audio compression/decompression
74/226
VIEW PATENT @ USPTO:  Full Text   PDF 

Government Rights Acknowledged 

US 08637011 Baron et al.
FUNDED BY
APPLICANT(S) Jody L. Baron (Mill Valley, California);  Lewis L. Lanier (Los Altos, California)
ASSIGNEE(S) The Regents of The University of California (Oakland, California)
INVENTOR(S) Jody L. Baron (Mill Valley, California);  Lewis L. Lanier (Los Altos, California)
ABSTRACT The present invention relates to methods and compositions for treating and/or preventing inflammation associated with viral infection and solid organ transplant rejection. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D.
FILED Friday, May 04, 2007
APPL NO 12/299608
ART UNIT 1648 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology
CURRENT CPC
Drug, bio-affecting and body treating compositions
424/130.100
VIEW PATENT @ USPTO:  Full Text   PDF 
US 08637759 Foster et al.
FUNDED BY
APPLICANT(S) Thomas E. Foster (Covington, Washington);  James Snyder (Mountain View, California)
ASSIGNEE(S) The Boeing Company (Chicago, Illinois)
INVENTOR(S) Thomas E. Foster (Covington, Washington);  James Snyder (Mountain View, California)
ABSTRACT A solar cell and method for producing same is disclosed. The solar cell includes a multijunction solar cell structure and a notch filter designed to reflect solar energy that does not contribute to the current output of the multijunction solar cell. By reflecting unused solar energy, the notch filter allows the solar cell to run cooler (and thus more efficiently) yet it still allows all junctions to fully realize their electrical current production capability.
FILED Friday, December 16, 2005
APPL NO 11/305434
ART UNIT 1759 — Organic Chemistry
CURRENT CPC
Batteries: Thermoelectric and photoelectric
136/243
VIEW PATENT @ USPTO:  Full Text   PDF 
US PP24198 Finn
FUNDED BY
APPLICANT(S) Chad Finn (Corvallis, Oregon)
ASSIGNEE(S) The United States of America, as represented by the Secretary Agriculture (Washington, District of Columbia)
INVENTOR(S) Chad Finn (Corvallis, Oregon)
ABSTRACT Description and specifications of a new and distinct red raspberry cultivar which originated from seed produced from open pollinated flowers of ‘Isabel’ (U.S. Plant Pat. No. 9,340) is provided. This new primocane fruiting cultivar can be distinguished by its high yields of large, very bright-red-colored, sweet, flavorful fruit with excellent fresh fruit quality borne on primocanes in late summer.
FILED Friday, September 02, 2011
APPL NO 13/199578
ART UNIT 1661 — Plants
CURRENT CPC
Plants
PLT/204
VIEW PATENT @ USPTO:  Full Text   PDF 

How To Use This Page 

THE FEDINVENT PATENT DETAILS PAGE

Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.

This week's information is published in the FedInvent Patents report for Tuesday, January 28, 2014.

The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.

HOW IS THE INFORMATION ORGANIZED?

Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.

WHAT INFORMATION WILL I FIND?

THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:

FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:

Department of Health and Human Services (HHS)
     National Institutes of Health (NIH)
         National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Department of Defense (DOD)
     Defense Advanced Research Projects Agency (DARPA)
         Army Research Office (ARO)

We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.

APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.

Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:

APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC

APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)

INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.

ABSTRACT
The abstract as it appears on the patent.

FILED
The date of the patent application including the day of the week.

APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.

ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:

3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices

You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.

CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.

The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.

The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.

  • A61B 1/149 (20130101)
  • A61B 1/71 (20130101)
  • A61B 1/105 (20130101)

The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.

VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.

HOW DO I FIND A SPECIFIC PATENT ON A PAGE?

You can use the Command F or Control F to find a specific patent you are interested in.

HOW DO I GET HERE?

You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.

You can also reach this page using the weekly page link that looks like this:

https://wayfinder.digital/fedinvent/patents-2014/fedinvent-patents-20140128.html

Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.

Download a copy of the How To Use This Page

HAVE MORE QUESTIONS?

info@wayfinder.digital